COMPU DAWN INC
S-8, 1997-11-03
COMPUTER INTEGRATED SYSTEMS DESIGN
Previous: INTERNATIONAL HOME FOODS INC, S-1/A, 1997-11-03
Next: KMG B INC, DEF 14A, 1997-11-03



    As filed with the Securities and Exchange Commission on November 3, 1997

                              Registration No. 333-

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM S-8
                             REGISTRATION STATEMENT
                                      UNDER
                           THE SECURITIES ACT OF 1933


                                COMPU-DAWN, INC.
             (Exact Name of Registrant as Specified in Its Charter)

                                    DELAWARE
         (State or Other Jurisdiction of Incorporation or Organization)

                                                                 11-3344575
                      (I.R.S. Employer Identification No.)

                  77 Spruce Street, Cedarhurst, New York 11516
                    (Address of Principal Executive Offices)

                     COMPU-DAWN, INC. 1996 STOCK OPTION PLAN
          COMPU-DAWN, INC. 1997 QUALIFIED EMPLOYEE STOCK PURCHASE PLAN
                              (Full Title of Plans)

                                 Mark Honigsfeld
                            Chairman of the Board and
                             Chief Executive Officer
                                Compu-DAWN, Inc.
                                77 Spruce Street
                           Cedarhurst, New York 11516
                            Telephone: (516) 374-6700
                           Telecopier: (516) 374-9410
            (Name, Address and Telephone Number of Agent for Service)

                  Copies of all communications and notices to:
                               Fred Skolnik, Esq.
                              Gavin C. Grusd, Esq.
                       Certilman Balin Adler & Hyman, LLP
                                90 Merrick Avenue
                           East Meadow, New York 11554
                            Telephone: (516) 296-7000
                           Telecopier: (516) 296-7111




<PAGE>





<TABLE>

<CAPTION>
                                                           CALCULATION OF REGISTRATION FEE

                                                                  Proposed                     Proposed
          Title of                                                 Maximum                      Maximum
        of Securities                   Amount                    Offering                     Aggregate                  Amount of
            To Be                        To Be                      Price                      Offering                 Registration
         Registered                  Registered(1)               Per Share                       Price                       Fee

Common Shares
 (par value
 $.01 per
<S>                                      <C>                             <C>     <C>       <C>           <C>                   <C> 
 share)                                  1,320,800(2)(3)                 $ 8.06  (4)       $ 10,645,648  (4)              $ 3,225.63
============================  ========================== =========================== ============================  =================
Common Shares
 (par value
 $.01 per
 share)                                        64,000(5)                        $.50                      $32,000              $9.70
============================  ========================== =========================== ============================  =================
Common Shares
 (par value
 $.01 per
 share)                                         3,250(6)                       $1.00                       $3,250              $0.98
============================  ========================== =========================== ============================  =================
Common Shares
 (par value
 $.01 per
 share)                                         8,250(7)                       $2.00                      $16,500              $5.00
============================  ========================== =========================== ============================  =================
Common Shares
 (par value
 $.01 per
 share)                                       185,500(8)                       $3.00                     $556,500            $168.64
============================  ========================== =========================== ============================  =================
Common Shares
 (par value
 $.01 per
 share)                                         3,250(9)                       $4.00                      $13,000              $3.94
============================  ========================== =========================== ============================  =================
Common Shares
 (par value
 $.01 per
 share)                                       25,000(10)                      $5.875                     $146,875             $44.51
============================  ========================== =========================== ============================  =================


                                                                     2

<PAGE>




============================  ========================== =========================== ============================  =================
Common Shares
 (par value
 $.01 per
 share)                                      389,950(11)                  $ 8.06 (4)         $ 3,142,997  (4)               $ 952.32
============================  ========================== =========================== ============================  =================
Common Shares
 (par value
 $.01 per
 share)                                      500,000(12)                  $ 8.06 (4)         $ 4,030,000  (4)             $ 1,221.09

Common Shares
 (par value
 $.01 per
 share)                                  250,000(13)(14)                 $ 8.06 (4)          $ 2,015,000  (4)               $ 610.55
============================  ========================== =========================== ============================  =================
Common Shares
 (par value
 $.01 per
 share)                                    2,360,050(15)                      $ 8.06              $ 19,022,003              $ --(16)

============================  ========================== =========================== ============================  =================
 Total                                                                                                                     $6,242.36
============================  ========================== =========================== ============================  =================
</TABLE>

(1)      Pursuant to Rule 416  promulgated  under the Securities Act of 1933, as
         amended (the "1933 Act"), an additional  indeterminate number of Common
         Shares is being  registered to cover any  adjustments  in the number of
         Common  Shares  pursuant  to  the   anti-dilution   provisions  of  the
         Compu-DAWN,  Inc.  1996 Stock  Option  Plan (the  "1996  Plan") and the
         Compu- DAWN,  Inc. 1997  Qualified  Employee  Stock  Purchase Plan (the
         "1997 Plan").

(2)      The 1996 Plan  authorizes the granting of options to purchase a maximum
         of 2,000,000  Common  Shares,  of which  options for the purchase of an
         aggregate of 679,200 Common Shares have been granted,  of which options
         for the  purchase of an aggregate  of 389,950  Common  Shares have been
         exercised.

(3)      Represents the issuance of Common Shares  issuable upon the exercise of
         options which may be granted under the 1996 Plan.

(4)      Estimated  solely  for the  purpose  of  calculating  the amount of the
         registration fee pursuant to Rule 457.

(5)      Represents the issuance of Common Shares  issuable upon the exercise of
         options which have been granted under the 1996 Plan at a purchase price
         of $.50 per Common Share.



<PAGE>



(6)      Represents the issuance of Common Shares  issuable upon the exercise of
         options which have been granted under the 1996 Plan at a purchase price
         of $1.00 per Common Share.

(7)      Represents the issuance of Common Shares  issuable upon the exercise of
         options which have been granted under the 1996 Plan at a purchase price
         of $2.00 per Common Share.

(8)      Represents the issuance of Common Shares  issuable upon the exercise of
         options which have been granted under the 1996 Plan at a purchase price
         of $3.00 per Common Share.

(9)      Represents the issuance of Common Shares  issuable upon the exercise of
         options which have been granted under the 1996 Plan at a purchase price
         of $4.00 per Common Share.

(10)     Represents the issuance of Common Shares  issuable upon the exercise of
         options which have been granted under the 1996 Plan at a purchase price
         of $5.875 per Common Share.

(11)     Represents  the  resale of  389,950  Common  Shares  acquired  upon the
         exercise  of  options  granted  to  certain  persons  who may be deemed
         affiliates of Compu-DAWN, Inc. (the "Registrant") under the 1996 Plan.

(12)     Represents a good-faith  estimate of the number of Common  Shares which
         may be  issuable  upon the  exercise  of  reload  options  which may be
         granted under the 1996 Plan.

(13)     The 1997 Plan authorizes the granting of options to purchase a maximum
         of 250,000 Common Shares.

(14)     Represents the issuance of Common Shares  issuable upon the exercise of
         options which may be granted under the 1997 Plan.

(15)     Represents  the resale of up to  2,360,050  Common  Shares which may be
         acquired upon the exercise of options granted, or which may be granted,
         to certain persons who may be deemed affiliates of the Registrant under
         the 1996 Plan and 1997 Plan.

(16)     Pursuant to Rule  457(h)(3),  no additional  filing fee is payable with
         respect to the  registration  of the resale of Common  Shares  issuable
         upon the exercise of options granted under the 1996 Plan and 1997 Plan.


                                EXPLANATORY NOTE

     Pursuant to General Instruction C of Form S-8, this Registration  Statement
contains (as Annex A hereto) a prospectus  meeting the requirements of Part I of
Form S-3  relating  to  reofferings  of Common  Shares,  $.01 par value,  of the
Registrant  acquired,  or which may be  acquired,  pursuant to the 1996 Plan and
1997  Plan,  respectively,  by  persons  who  may be  deemed  affiliates  of the
Registrant.


<PAGE>



                                     PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3.  Incorporation of Documents by Reference

     Incorporated  herein by reference are the following  documents filed by the
Registrant with the Securities and Exchange  Commission (the "Commission") under
the 1933 Act and the  Securities  Exchange  Act of 1934,  as amended  (the "1934
Act"), as the case may be:

                  (a) The prospectus  included in the Registrant's  Registration
Statement  on Form SB-2  (File  No.  333-18667)  (the  "Form  SB-2  Registration
Statement"),  which was declared  effective by the  Commission  on June 10, 1997
under the 1933 Act.

                  (b) The  Registrant's  Quarterly  Report  on Form  10-QSB,  as
amended, for the three months ended June 30, 1997.

                  (c)  The  description  of  the   Registrant's   Common  Shares
contained  in the  Registrant's  Registration  Statement  on Form 8-A  (File No.
000-22611),  which was  declared  effective by the  Commission  on June 10, 1997
under the 1934 Act.

     All documents filed by the Registrant pursuant to Sections 13, 14 and 15(d)
of the 1934 Act  prior  to the  filing  of a  post-effective  amendment  to this
Registration  Statement which indicates that all securities  offered hereby have
been sold or which deregisters all such securities then remaining unsold,  shall
be deemed to be  incorporated  herein by reference  and to be a part hereof from
their respective dates of filing.

Item 4.           Description of Securities

                  Not applicable.

Item 5.           Interests of Named Experts and Counsel

                  Certain legal  matters in connection  with the offering of the
securities  registered  hereunder  are being passed upon for the  Registrant  by
Certilman  Balin Adler & Hyman,  LLP, 90 Merrick Avenue,  East Meadow,  New York
11554.

Item 6.           Indemnification of Directors and Officers

                  Article X of the  Registrant's  Certificate  of  Incorporation
eliminates  the  personal  liability  of  directors  to the  Registrant  and its
stockholders  for monetary damages for breach of fiduciary duty as a director to
the fullest extent permitted by Section 102 of the Delaware General  Corporation
Law,  provided that this provision shall not eliminate or limit the liability of
a director


                                      II-1

<PAGE>



(i) for any breach of the  director's  duty of loyalty to the  Registrant or its
stockholders,  (ii) for acts or  omissions  not in good  faith or which  involve
intentional  misconduct  or a knowing  violation  of law,  (iii)  arising  under
Section 174 of the Delaware  General  Corporation  Law (with respect to unlawful
dividend payments and unlawful stock purchases or redemptions),  or (iv) for any
transaction from which the director derived an improper personal benefit.

     Additionally,   the   Registrant   has  included  in  its   Certificate  of
Incorporation and its by-laws  provisions to indemnify its directors,  officers,
employees and agents and to purchase insurance with respect to liability arising
out of the  performance  of their duties as directors,  officers,  employees and
agents as permitted by Section 145 of the Delaware General  Corporation law. The
Delaware  General  Corporation  law provides  further  that the  indemnification
permitted  thereunder shall not be deemed exclusive of any other rights to which
the  directors,  officers,  employees  and  agents  may be  entitled  under  the
Registrant's by-laws, any agreement, vote of stockholders or otherwise.

     The effect of the  foregoing  is to require  the  Registrant  to the extent
permitted by law to indemnify the officers,  directors,  employees and agents of
the  Registrant  for any claim  arising  against such persons in their  official
capacities if such person acted in good faith and in a manner that he reasonably
believed to be in or not opposed to the best interests of the  Registrant,  and,
with respect to any criminal  action or proceeding,  had no reasonable  cause to
believe his conduct was unlawful.

     Insofar as indemnification for liabilities arising under the Securities Act
may be permitted to directors,  officers or persons  controlling  the Registrant
pursuant to the foregoing provisions,  the Registrant has been informed that, in
the opinion of the Securities and Exchange  Commission,  such indemnification is
against  public  policy as  expressed  in the  Securities  Act and is  therefore
unenforceable.

Item 7.           Exemption from Registration Claimed

     The 389,950 outstanding Common Shares to be reoffered or resold pursuant to
this Registration  Statement were acquired in private transactions not involving
a public offering that were exempt from the registration  provisions of the 1933
Act pursuant to Section 4(2) thereof. The Company determined that the holders of
such Common Shares were sophisticated investors. Sales of the Common Shares were
without  the  use  of  an  underwriter,  and  the  certificates  evidencing  the
securities bear  restrictive  legends  permitting the transfer thereof only upon
registration of such securities or pursuant to an exemption under the 1933 Act.









                                      II-2

<PAGE>



Item 8.           Exhibits

                  4.1      Specimen Common Stock Certificate(1)
                  5        Opinion of Certilman  Balin Adler & Hyman,  LLP as to
                           the legality of the Common Shares  issuable  pursuant
                           to  the  1996  Plan  and  the  1997  Plan  and  being
                           registered hereunder
                  10.1     1996 Stock Option Plan(1)
                  10.2     1997 Qualified Employee Stock Purchase Plan, as 
                           amended
                  23.1     Consent of Lazar Levine & Company, LLP
                  23.2     Consent  of  Certilman  Balin  Adler  &  Hyman,   LLP
                           (included in its opinion filed as Exhibit 5)
                  24 Powers of Attorney  (included in  signature  page forming a
part hereof)

Item 9.           Undertakings

                  The undersigned Registrant will:

                  (1)  File,  during  any  period  in which it  offers  or sells
securities, a post-effective amendment to this registration to:

                         (i) Include any prospectus required by Section 10(a)(3)
                    of the Securities Act;

                         (ii)  Reflect  in the  prospectus  any  facts or events
                    which,  individually  or together,  represent a  fundamental
                    change in the  information  in the  registration  statement.
                    Notwithstanding  the foregoing,  any increase or decrease in
                    volume of  securities  offered (if the total dollar value of
                    securities   offered   would  not  exceed   that  which  was
                    registered)  and any  deviation  from the low or high end of
                    the estimated maximum offering range may be reflected in the
                    form of  prospectus  filed with the  Commission  pursuant to
                    Rule 424(b) if, in the aggregate,  the changes in volume and
                    price  represent  no more  than a 20  percent  change in the
                    maximum   aggregate   offering   price   set  forth  in  the
                    "Calculation  of  Registration  Fee" table in the  effective
                    registration statement.

                         (iii)  Include  any  additional  or  changed   material
                    information on the plan of distribution.

                  (2) For determining  liability under the Securities Act, treat
each post-effective  amendment as a new registration statement of the securities
offered,  and the offering of the  securities at the time to be the initial bona
fide offering.


- --------------------

         (1) Denotes document filed as an exhibit to the Registrant's  Form SB-2
Registration  Statement (File No.  333-18667)  which is  incorporated  herein by
reference thereto.

                                      II-3

<PAGE>



                  (3)  File  a   post-effective   amendment   to   remove   from
registration  any  of the  securities  that  remain  unsold  at  the  end of the
offering.


                                      II-4

<PAGE>



                                   SIGNATURES

     Pursuant to the  requirements of the Securities Act of 1933, the Registrant
certifies  that it has  reasonable  grounds to believe  that it meets all of the
requirements  for  filing  on Form S-8 and has  duly  caused  this  Registration
Statement  to be  signed  on its  behalf  by  the  undersigned,  thereunto  duly
authorized,  in the  County of  Nassau,  State of New  York,  on the 31st day of
October, 1997.

                                           COMPU-DAWN, INC.

                                           By:        /s/ Mark Honigsfeld
                                                      Mark Honigsfeld
                                                      Chairman of the Board and
                                                      Chief Executive Officer



                                POWER OF ATTORNEY

Know all men by these presents,  that each person whose signature  appears below
constitutes  and appoints Mark Honigsfeld with full power to act as his true and
lawful   attorney-in-fact  and  agent,  with  full  power  of  substitution  and
resubstitution  for  him  and in his  name,  place  and  stead,  in any  and all
capacities to sign any and all amendments (including post-effective  amendments)
to this Registration Statement, and to file the same, with all exhibits thereto,
and other  documents in connection  therewith  with the  Securities and Exchange
Commission,  granting  unto said  attorney-in-fact  and  agent,  and each of his
substitutes,  full power and  authority to do and perform each and every act and
thing  requisite or necessary to be done in and about the premises,  as fully to
all intents and purposes as he might or could do in person, hereby ratifying and
confirming  all that said  attorney-in-fact  and  agent,  or his  substitute  or
substitutes, may lawfully do or cause to be done by virtue hereof.



                                      II-5

<PAGE>



     Pursuant  to  the   requirements  of  the  Securities  Act  of  1933,  this
Registration  Statement  has been signed below by the  following  persons in the
capacities and on the dates indicated.
<TABLE>

<S>                                        <C>                                              <C>
Signature                                      Capacity                                            Date


/s/ Mark Honigsfeld                         Chairman of the Board,                        October 31, 1997
- ------------------------------              Chief Executive Officer,
Mark Honigsfeld                             Secretary and Director
                                            (Principal Financial Officer
                                            and Principal Accounting Officer)

/s/ Dong W. Lew                             President, Chief Operating                    October 31, 1997
- --------------------------------            Officer, Treasurer and
Dong W. Lew                                 Director         
                                            

/s/ Louis Libin                             Chief Technology Officer and
- --------------------------------            Director                                      October 31, 1997
Louis Libin                                                                     


/s/ William D. Rizzardi                     Director                                      October 31, 1997
- --------------------------------
William D. Rizzardi

/s/ Harold Lazarus                          Director                                      October 31, 1997
Harold Lazarus, Ph.D.
</TABLE>


                                      II-6

<PAGE>



                                     ANNEX A

                                   PROSPECTUS


                                  COMMON SHARES


                                COMPU-DAWN, INC.

     This  Prospectus  relates  to the  sale or  offer  for  sale on the  Nasdaq
SmallCap Market, or otherwise,  of an aggregate of 2,750,000 Common Shares, $.01
par value (the "Common  Shares"),  of Compu-DAWN,  Inc., a Delaware  corporation
(the "Company"), 389,950 of which have been acquired, and 2,360,050 of which may
be acquired,  by certain  persons who may be deemed  affiliates  of the Company,
pursuant to the  exercise  by them of options  granted (or which may be granted)
pursuant to the terms of the Company's  1996 Stock Option Plan (the "1996 Plan")
and the Company's 1997  Qualified  Employee Stock Purchase Plan (the "1997 Plan"
and  collectively  with the 1996 Plan,  the "Plans") as well as such  additional
Common  Shares as may become  issuable  upon the  exercise of options  under the
Plans, including Common Shares which may be acquired pursuant to the exercise of
reload options which may be granted thereunder.

     The  various  persons  and  entities  referred  to herein  are  hereinafter
referred to  individually  as a "Selling  Shareholder"  and  collectively as the
"Selling  Shareholders".  There are no commitments pursuant to which the Company
will  receive any proceeds  from the resale of the Common  Shares by the Selling
Shareholders. See "Selling Shareholders."

     A PURCHASE OF THESE SECURITIES INVOLVES A CERTAIN DEGREE OF RISK. SEE "RISK
FACTORS." THE "RISK FACTORS" SECTION BEGINS ON PAGE A-5 OF THIS PROSPECTUS.


     THESE  SECURITIES  HAVE NOT BEEN APPROVED OR  DISAPPROVED BY THE SECURITIES
AND EXCHANGE  COMMISSION (THE  "COMMISSION")  NOR HAS THE COMMISSION PASSED UPON
THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS.  ANY REPRESENTATION TO THE CONTRARY
IS A CRIMINAL OFFENSE.


     The Selling  Shareholders,  directly through agents designated by them from
time to time or through  broker-dealers  or underwriters  also to be designated,
may  sell  the  Common  Shares,  from  time to  time,  in or  through  privately
negotiated  transactions,  or in  one  or  more  transactions,  including  block
transactions,  on the Nasdaq  SmallCap  Market,  or on any other market or stock
exchange on which the Common Shares may be listed in the future  pursuant to and
in accordance with the applicable rules of such market or exchange or otherwise.
The selling price of the Common

                                       A-1

<PAGE>



Shares may be at market prices prevailing at the time of sale, at prices related
to  such  prevailing  market  prices  or  at  negotiated  prices.  See  "Selling
Shareholders" and "Plan of Distribution".

     The Selling  Shareholders and any agents,  broker-dealers,  or underwriters
that participate with the Selling Shareholders in the distribution of any of the
Common  Shares  may be deemed to be  "underwriters"  within  the  meaning of the
Securities  Act of 1933,  as  amended  (the  "1933  Act"),  and any  commissions
received by them, and any profit on the resale of the Common Shares purchased by
them, may be deemed to be  underwriting  commissions or discounts under the 1933
Act. The Company is not aware of any underwriting  arrangements  with respect to
the  resale of the  Common  Shares by the  Selling  Shareholders.  See  "Selling
Shareholders" and "Plan of Distribution".

     The Company's  Common Shares are traded on the Nasdaq SmallCap Market under
the symbol  "CODI".  On October 27, 1997,  the closing  price for the  Company's
Common Shares, as reported by The Nasdaq Stock Market, was $8 1/2 per share.




                                November 3, 1997


                                       A-2

<PAGE>



NO  DEALER,  SALESMAN  OR ANY  OTHER  PERSON  HAS  BEEN  AUTHORIZED  TO GIVE ANY
INFORMATION OR TO MAKE ANY  REPRESENTATION NOT CONTAINED IN THIS PROSPECTUS AND,
IF GIVEN OR MADE, SUCH INFORMATION OR REPRESENTATION  MUST NOT BE RELIED UPON AS
HAVING BEEN AUTHORIZED BY THE COMPANY OR ANY OTHER PERSON.  THIS PROSPECTUS DOES
NOT CONSTITUTE AN OFFER TO SELL OR A  SOLICITATION  OF AN OFFER TO BUY TO ANYONE
IN ANY  JURISDICTION IN WHICH SUCH OFFER OR SOLICITATION IS NOT AUTHORIZED OR IN
WHICH THE PERSON MAKING SUCH OFFER OR SOLICITATION IS NOT QUALIFIED TO DO SO, OR
TO ANYONE TO WHOM IT IS UNLAWFUL TO MAKE SUCH OFFER OR SOLICITATION. NEITHER THE
DELIVERY  OF THIS  PROSPECTUS  NOR ANY SALE  MADE  HEREUNDER  SHALL,  UNDER  ANY
CIRCUMSTANCES,  CREATE ANY IMPLICATION THAT ANY INFORMATION  CONTAINED HEREIN IS
CORRECT AS OF ANY TIME SUBSEQUENT TO THE DATE HEREOF.



                              AVAILABLE INFORMATION

     For further  information  with respect to the Company and the Common Shares
offered hereby, reference is hereby made to the Company's Registration Statement
on  Form  SB-2  (File  No.  333-18667),  which  was  declared  effective  by the
Commission  on June 10, 1997 (the "Form SB-2  Registration  Statement")  and the
exhibits thereto. Additionally, the Company files reports, proxy and information
statements  and  other   information   with  the  Commission.   Such  Form  SB-2
Registration Statement and the exhibits thereto,  reports,  statements and other
information filed by the Company with the Commission can be inspected and copied
at the public  reference  facilities  maintained by the  Commission at Judiciary
Plaza,  450 Fifth  Street,  N.W.,  Washington,  D.C.  20549 and at the following
Regional Offices of the Commission:  7 World Trade Center, Suite 1300, New York,
New York 10048;  and  Citicorp  Center,  500 West  Madison  Street,  Suite 1400,
Chicago, Illinois 60661-2511.  Copies of such material can also be obtained from
the Public  Reference  Section of the Commission at Judiciary  Plaza,  450 Fifth
Street,  N.W.,  Washington,  D.C. 20549 at prescribed  rates.  Furthermore,  the
Commission  maintains a Web site that contains  reports,  proxy and  information
statements and other information  regarding the Company. The address of such Web
site is http://www.sec.gov.




                                       A-3

<PAGE>



                 INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE

     The  documents  listed  below  have  been  filed  by the  Company  with the
Commission  under  the  1933 Act and the  Securities  Exchange  Act of 1934,  as
amended (the "1934  Act"),  as the case may be, and are  incorporated  herein by
reference:

          (a) The prospectus  included in the Company's  Form SB-2  Registration
     Statement.

          (b) The Company's Quarterly Report on Form 10-QSB, as amended, for the
     three months ended June 30, 1997.

          (c) The  description of the Company's  Common Shares  contained in the
     Company's  Registration  Statement  on  Form  8-A,  as  amended  (File  No.
     000-22611),  which was  declared  effective by the  Commission  on June 10,
     1997.

     All documents filed by the Company pursuant to Sections 13(a), 13(c), 14 or
15(d)  of the 1934  Act  after  the  date of this  Prospectus  and  prior to the
termination  of the offering of the Common Shares offered hereby shall be deemed
to be  incorporated  by reference  into this  Prospectus and to be a part hereof
from their respective dates of filing.

     The Company  will provide  without  charge to each person to whom a copy of
this  Prospectus  is  delivered,  upon the  written or oral  request of any such
person, a copy of any or all of the documents  referred to above which have been
incorporated  into this  Prospectus  by reference  (other than  exhibits to such
documents).  Requests for such copies  should be directed to the  Secretary,  77
Spruce Street, Cedarhurst, New York 11516 (telephone number: (516) 374-6700).

     Any  statement  contained  in a document  incorporated  herein by reference
shall be deemed to be modified or superseded for purposes of this  Prospectus to
the extent  that a  statement  contained  herein  modifies  or  supersedes  such
statement.  Any statement so modified or superseded shall not be deemed,  except
as so modified or superseded, to constitute a part of this Prospectus.


                                       A-4

<PAGE>



                                   THE COMPANY

     Compu-DAWN,  Inc. (the  "Company") is primarily  engaged in the business of
designing,  developing,  licensing,  installing and servicing  computer software
products  and  systems  for law  enforcement  and public  safety  agencies.  The
software systems include computer-aided  dispatching,  computer interfacing with
state and national crime  information  databases,  advanced mobile on-line radio
computing,  automatic vehicle location (employing dynamic map displays), records
management  and  photo-image  database  systems.  Certain of these  applications
utilize   telecommunications   and  space   satellite   technology,   and  other
infrastructure,  provided by third parties. The Company has developed,  licensed
and  installed  its  systems in more than 58 agencies  primarily  located in the
State of New York.

     The Company was incorporated under the name Coastal Computer Systems,  Inc.
in New York on March  31,  1983 and was  reincorporated  in  Delaware  under its
present name on October 18, 1996.

     The  Company's   executive   offices  are  located  at  77  Spruce  Street,
Cedarhurst, New York 11516 and its telephone number is (516) 374-6700.

                           FORWARD-LOOKING STATEMENTS

     The Company cautions readers that certain  important factors may affect the
Company's actual results and could cause such results to differ  materially from
any  forward-looking  statements  which  may be deemed to have been made in this
Prospectus or which are otherwise made by or on behalf of the Company.  For this
purpose,  any statements contained in this Prospectus that are not statements of
historical fact may be deemed to be forward-looking statements. Without limiting
the  generality  of the  foregoing,  words  such  as  "may",  "will",  "expect",
"believe",  "anticipate",  "intend",  "could",  "estimate", or "continue" or the
negative  variations thereof or comparable  terminology are intended to identify
forward-looking  statements.  Factors  which may  affect the  Company's  results
include, but are not limited to, the risks and uncertainties associated with the
sale,  implementation and maintenance of computer software products and systems.
The Company is also subject to other risks detailed herein or detailed from time
to time in the  Company's  Commission  filings.  Factors  that  could  cause  or
contribute to such difference  include,  but are not limited to, those discussed
in "Risk Factors" below, as well as those discussed elsewhere in this Prospectus
and in the Company's filings with the Commission.

                                  RISK FACTORS

     An investment in the securities  offered hereby is speculative and involves
a high degree of risk and should only be purchased  by investors  who can afford
to lose their  entire  investment.  Prospective  purchasers,  prior to making an
investment,  should  carefully  consider  the  following  risks and  speculative
factors, as well as other information set forth elsewhere in this Prospectus. As
discussed   above,   this  Prospectus   contains,   in  addition  to  historical
information,  forward-looking  statements that involve risks and  uncertainties.
The Company's

                                       A-5

<PAGE>



actual results could differ  materially.  Factors that could cause or contribute
to such difference  include,  but are not limited to, those discussed  below, as
well as those discussed elsewhere in this Prospectus.

         1. Downward Trend in Revenues;  Current Period and  Anticipated  Future
Losses.  For the years ended December 1996 and 1995, the Company's revenues were
$477,527  and  $1,040,181,  respectively.  For the first six  months of 1997 and
1996,  the Company's  revenues were  $300,686 and  $313,259,  respectively.  The
decline in revenues between 1995 and 1996 was primarily the result of a decrease
in software  sales (i.e.  fewer units sold) which  occurred due to the Company's
focus on raising  capital  (commencing  in late 1995 and  continuing  throughout
1996),  strategic  planning,  and the  allocation  and  devotion of  substantial
personnel  time to the  development  of visual  computer-aided  dispatching  (or
V-CAD) and new wireless mobile computing  technology.  Such actions diverted the
Company's resources away from sales activities. Since December 1996, the Company
has not generated significant  revenues.  The Company believes that, through the
net  proceeds of  approximately  $5,764,000  realized in the  Company's  initial
public offering, which proceeds are intended to be used for product enhancement,
marketing  and the  introduction  of new  products,  the Company will be able to
increase revenues over the long term; however, the significance of such increase
cannot  be  determined.  For the year  ended  December  31,  1996,  the  Company
experienced  a net loss of $570,769.  For the first six months of 1997 and 1996,
the Company had a net loss of $1,322,577 and $23,921, respectively. The net loss
figures are the result of the  incurrence of  significant  expenses,  including,
without  limitation,  research and development  expenses,  costs relating to the
enhancement and refining of the Company's current product line, marketing costs,
obligations under new key employee  compensation  agreements,  the lease for the
Company's premises which commenced in September 1996, and general administrative
expenses. Furthermore, the net loss figures for the first six months of 1997 and
1996 are  also  attributable  to the fact  that  the  Company  did not  generate
significant  revenues in such  periods,  though the Company  expects to generate
revenues  in  the  long  term  as  a  result  of  product  enhancement  and  the
introduction  of new products  funded by the net proceeds of its initial  public
offering.  The Company  believes that, for the  foreseeable  future,  it will be
unable to achieve  sufficient  additional  revenues  to offset  the  anticipated
significant   operating  costs  described   above.   Accordingly,   the  Company
anticipates that operating losses will continue at least for the next 12 months.
The  Company  cannot  predict  the  length of time such  operating  losses  will
continue  or the  impact  such  operating  losses  will  have  on its  financial
condition  and  results  of  operations.  There  can be no  assurance  that  the
Company's  technology and products will be able to compete  successfully  in the
marketplace and/or generate  significant revenue, or that the Company's business
will be able to operate profitably.

     The Company's quarterly operating results have, in the past, varied and may
in the future vary  significantly,  depending on facts such as the size,  timing
and  recognition  of  revenue  from   significant   software  sales  and  system
integration activity,  the time of new product releases and market acceptance of
these new releases,  and increases in operating  expenses.  Thus,  the Company's
revenues and results of operations  have and may continue to vary  significantly
from quarter to quarter, period to period, and year to year based upon frequency
and volume of sales and licensing of the  Company's  software  applications  and
providing of consulting services during such period. Due to the relatively fixed
nature of certain of the Company's costs throughout each quarterly period,

                                       A-6

<PAGE>



including personnel and facilities costs, the decline of revenues in any quarter
typically  results  in lower  profitability  in that  quarter.  There  can be no
assurance that the Company will become  profitable or avoid losses in any future
period.

         2.   Evolving   Market;   New   Product   Development;    Technological
Obsolescence.  The markets  for the  Company's  products  are  characterized  by
evolving  industry  requirements,  rapid  technological  change and frequent new
product  introductions  which may result in product or technology  obsolescence.
Certain  companies  may be  developing  technologies  or  products  of which the
Company is unaware which may be functionally  similar,  or superior,  to some or
all of those offered by the Company.  As a result, the ability of the Company to
compete  will depend on its ability to adapt,  enhance and improve its  existing
products and technology and, if necessary, to develop and introduce new products
and  technology to the  marketplace  in a timely and cost-  competitive  manner.
There can be no assurance that the Company will be able to compete successfully,
that its  competitors or future  competitors  will not develop  technologies  or
products  that  render the  Company's  products or  technology  obsolete or less
marketable,  or that  the  Company  will be able  to  successfully  enhance  its
products or technology or adapt them satisfactorily.

     New product development efforts are subject to all of the risks inherent in
the development of new technology and products including  unanticipated  delays,
expenses,   technical  problems  or  difficulties,   as  well  as  the  possible
insufficiency of funding to complete  development.  There can be no assurance as
to when, or whether, new products will be successfully  developed.  In addition,
no assurance can be given that additional technologies can be developed within a
reasonable  development schedule, if at all. Further,  there can be no assurance
that the Company would have  sufficient  economic or human resources to complete
such  development  in a timely  manner,  or at all,  or that it could enter into
economically  reasonable  arrangements  for the  completion  of such products by
third parties.

     Following  the  development  of  additional  products,   the  Company  must
successfully  complete a testing  program  for the  products  before they can be
marketed.  Although the Company  believes that its testing  program is adequate,
unforeseen  technical  problems arising out of such testing could  significantly
and adversely affect the Company's  ability to produce and market a commercially
acceptable  product.  In addition,  the  Company's  success will depend upon its
current and proposed  technologies  and  products  meeting  acceptable  cost and
performance  criteria in the  marketplace.  There can be no  assurance  that the
technologies and products will meet applicable  price or performance  objectives
or that  unanticipated  technical or other  problems  will not occur which would
result in increased costs or material  delays.  Also,  there can be no assurance
that new  technologies  will be  developed  in the  future  by the  Company.  If
superior technology is developed by the Company's competitors, such products may
render the Company's present products obsolete, and thus would have a materially
negative impact on the Company.

         3. Failure to Integrate  Various Product  Introductions  and Offerings.
The Company believes that significant market  opportunities exist for a provider
of fully integrated software designed for the public safety marketplace.  One of
the  Company's  business  strategies  is to  provide  a "total  solution"  fully
integrated software product line used in public safety. Although the Company

                                       A-7

<PAGE>



has had some success in the past  integrating  its software  products with other
systems,  there  can be no  assurance  that  the  Company  will be able to fully
integrate these applications,  or newly created applications,  or that achieving
such integration will enable the Company to improve its competitive  position in
the software market.  Moreover, the Company's inability to further integrate its
products  could have a material  adverse  effect on the  Company's  business and
results of operations.

         4.  Dependence  on  Strategic   Business  Alliances  and  Subcontractor
Relationships.  Historically,  the Company's  customers  have been in the "small
size" and "medium  size" market  segments  (i.e.  public safety  departments  or
agencies  with  fewer  than 200 sworn  officers  or  personnel).  The  Company's
business  strategy  includes  the  development  of systems for the "large  size"
market segment.  In order to enter such market, the Company,  in all likelihood,
will  need  to  establish  strategic  business  alliances  and/or  subcontractor
relationships  with large  systems  integrators  and public  network  providers.
Business alliances have been entered into with AT&T Wireless Data, Inc. ("AT&T")
and GTE Mobilnet  Service Corp.  ("GTE"),  and a subcontractor  relationship has
been  established  with  Data  General   Corporation  ("Data  General").   These
arrangements  set forth the relationship of the parties in the event of a system
installation and do not relate to a particular  customer.  To date, no customers
have been secured under these  arrangements,  no revenues have been derived from
these  arrangements  and no  assurances  can be given that any revenues  will be
derived from these arrangements in the future. The agreement between the Company
and AT&T provides,  among other things,  (i) minimum technical support standards
(if  technical  support is required in a  particular  project)  which if not met
could result in a reduction of the amount of technical  support fees paid to the
Company,  and (ii) minimum revenue requirements to entitle the Company to a goal
attainment   fee.   Additionally,   failure  to  meet  certain  minimum  revenue
requirements will give AT&T the right to terminate the agreement.  The agreement
between the Company and GTE provides, among other things, that GTE has the right
not to pay the Company any  compensation  during any period in which the Company
fails to materially perform its obligations. No assurances can be given that, in
the event any projects are undertaken under the above described agreements,  the
Company will meet any of the imposed  standards,  minimum revenue levels will be
achieved, or the Company will be able to materially perform its obligations.  If
any of these standards or levels are not met, the Company's  compensation may be
reduced or eliminated  and possibly  result in early  termination  of certain of
these agreements.  In addition, no assurances can be given that the Company will
renew its current, or enter into any other,  business alliances or subcontractor
relationships.  The  failure  of the  Company  to  maintain  or enter  into such
alliances  or  relationships  would  have a  material  adverse  effect  upon the
Company's ability to implement its business plan.

         5. Intellectual  Property  Protection and  Infringement.  The Company's
technology   is  not   patented  and  the  Company  has  not  filed  any  patent
applications.  The  Company  instead  currently  relies  on  trade  secrets  and
copyright  rights to establish  and protect  certain  proprietary  rights in its
products.  These  measures  afford  limited  protection,  and  there  can  be no
assurance  that the steps  taken by the  Company  to protect  these  proprietary
rights will be adequate to prevent  misappropriation  of its  technology  or the
independent  development by others of similar  technology  especially in view of
the limited  resources of the Company and the potential cost of any legal action
to enforce such rights.

                                       A-8

<PAGE>




     The Company has not obtained any copyright registrations. Registration of a
copyright with the United States copyright office is not a requirement to make a
copyright legally effective,  but generally provides a rebuttable presumption of
its  validity.  In the absence of a  registered  copyright,  the Company will be
unable  to bring an  action  for  copyright  infringement.  A  copyright  may be
registered at any time prior to bringing an infringement  action. If the Company
registers a copyright after the  infringement  occurs (and prior to bringing the
infringement  action),  it may be limited  in its  ability to prove its case and
will be precluded from seeking  statutory damages (in lieu of actual damages and
lost  profits)  and  attorney's  fees.  The Company  intends to seek  registered
copyright  protection  under  United  States  law  with  respect  to some of its
software,  although no assurance  can be given that the Company will obtain such
protection.  While the Company  believes  that it would be  impractical  and not
cost-effective  for a third party to attempt to copy  software such as that used
in its  products,  unauthorized  parties,  nevertheless,  might  attempt to copy
aspects, or reverse engineer certain,  of the Company's products,  or may obtain
and use information  that the Company  regards as proprietary.  The cost of, and
time dedicated to,  enforcement  by the Company of its rights,  if any, could be
significant.  Regardless of the outcome of such enforcement  proceedings,  there
can be no  assurance  that such  proceedings  will be  effective.  In  addition,
although the Company  believes  that there are no  infringement  or trade secret
misappropriation  claims against the Company and no grounds for the assertion of
any such claims,  the cost of  responding  to any such  assertion,  should it be
made,  could be  significant  and there is no assurance  that the Company  would
prevail.

         6. Competition.  The Company's  products compete with those of numerous
well-established  companies,  which  design,  sell,  produce or market  software
systems for public safety operations. Many of these companies have substantially
greater financial,  technical and other resources than those of the Company, and
they may have established reputations for success in the development, licensing,
sale and service of their products and technology.  Certain of those competitors
have the financial resources  necessary to enable them to withstand  substantial
price competition or downturns in the market for computer software products used
by  public  safety  agencies  and  organizations.   In  addition,   the  Company
anticipates  that a material  portion of the sale of its  products  will be made
through the competitive bid process.  There can be no assurance that the Company
will be able to compete effectively in such process.

         7.  Limited  Sales and  Marketing  Experience.  The Company has limited
experience  in the areas of sales,  marketing  and  distribution.  The Company's
sales and marketing staff will require additional personnel in the future. There
can be no assurance that the Company will be able to build an adequate sales and
marketing  staff,  that  establishing  such a sales and marketing  staff will be
cost-effective,  or that the  Company's  sales  and  marketing  efforts  will be
successful.

         8. Dependence on Significant Customers. Although the composition of the
Company's  largest  customers  has changed from year to year,  historically  the
Company's  revenues  have  been  materially  dependent  on a  limited  number of
customers.  Generally,  the Company does not receive  repeat  business  from its
customers for the design and installation of software systems. Further

                                       A-9

<PAGE>



revenues from  customers to whom the Company has licensed  software  systems are
usually derived from maintenance and support contracts. Accordingly, the Company
does not believe  that the make-up of its  current  customers  is material to an
understanding  of the Company's  future  business  prospects.  While the Company
expects  its  customer  base to continue  to expand,  a limited  number of large
customers  may continue to account for a  significant  portion of the  Company's
sales during any given period for the foreseeable future. As such, the Company's
financial  condition  and results of operations  may be adversely  affected by a
delay,  reduction or  cancellation  of orders from one or more of its current or
future significant customers or the loss of one or more such customers.

         9. Product  Concentration.  Licensing of products and the  provision of
maintenance and support services to the law enforcement and public safety market
represented  substantially  all of the  Company's  revenues for the fiscal years
ended  December  31,  1995 and 1996 and the  first six  months of 1997,  and are
expected  to  continue  to account  for all of the  Company's  revenues  for the
foreseeable future. Any factors adversely affecting the Company's products, such
as the introduction of superior  competitive  products or shifts in the needs of
the marketplace, would have a material adverse effect on the Company's financial
condition and results of operations.

         10. Lengthy Sales Cycle.  Licensing of the Company's  software products
typically involves a detailed technical  evaluation and a commitment of capital,
technical,  marketing and other resources,  with the attendant delays frequently
associated  with  customers'   internal  procedures  to  approve  large  capital
expenditures and to test and accept new technologies  that affect the customer's
operations  infrastructure.  For  those  and  other  reasons,  the  sales  cycle
associated  with the  Company's  products is typically  lengthy and subject to a
number of significant  risks,  including  customers'  budgetary  constraints and
internal acceptance procedure, that are beyond the Company's control. Because of
the lengthy  sales cycle and the  generally  large size of customer  orders,  if
revenues forecasted from a specific customer for a particular fiscal quarter are
not realized in that quarter,  the Company's  operating results for that quarter
could be materially adversely affected.

         11. New Management Team;  Dependence on Executive  Management;  Need to
Retain Key Personnel.  The Company's executive management team, Mark Honigsfeld,
Chairman of the Board and Chief Executive  Officer of the Company,  Dong W. Lew,
President and Chief  Operating  Officer of the Company,  and Louis Libin,  Chief
Technology Officer of the Company, have worked together for only a brief period.
Mr.  Honigsfeld was elected  Chairman of the Board of the Company in August 1996
and was elected Chief Executive  Officer of the Company  effective as of October
1, 1996.  Mr.  Libin was  elected as a director  of the  Company  and became the
Company's  Chief  Technology  Officer in January 1997 and only began  serving as
Chief Technology Officer on a full-time basis in March 1997.

                  The Company has a three-year employment agreement with each of
Messrs. Honigsfeld, Lew and Libin, each of which includes, among other things, a
non-competition  and  non-  solicitation  provision.   However,  each  agreement
provides that the employee can  terminate his agreement  with the Company at any
time  upon 30  days  notice  for  any  reason.  Additionally,  Mr.  Honigsfeld's
employment agreement allows him to devote up to 10% of his working time, and Mr.

                                      A-10

<PAGE>



Libin's employment agreement allows him to devote up to one day a week, to other
endeavors which are not competitive  with the Company.  The loss of the services
of either Mr.  Honigsfeld,  Mr. Lew or Mr.  Libin could have a material  adverse
effect on the Company's business.

     The Company has obtained  "key-man" life insurance policies on the lives of
Messrs.  Honigsfeld and Libin, each of which provides for a death benefit to the
Company of  $1,000,000.  The Company  has been  unable to secure life  insurance
coverage for Mr. Lew in light of his age and history as a smoker. With regard to
Messrs.  Honigsfeld and Libin,  there can be no assurance that the death benefit
would be  adequate to fund the  Company's  needs  until a  replacement  could be
found.

     The success of the Company is also  dependent  upon its ability to hire and
retain  additional  qualified  and talented  executive,  technical and marketing
personnel.  There is always intense  competition for qualified  personnel in the
Company's business and its inability to recruit qualified personnel could have a
material adverse effect on its business and results of operations.  There can be
no assurance  that the Company will be able to retain the members of its current
management or  personnel,  or that it will be able to  successfully  attract and
retain  qualified  management,  engineering  and sales or other personnel in the
future.

         12. Dependence on Licensors.  The Company currently relies on operating
system software owned by certain third parties for certain software and platform
operating  systems  which the Company uses to create its  products,  and in some
cases  to  bundle  with its own  software  in its  products.  The  licenses  are
perpetual  in  duration  subject  to the  payment of an annual  maintenance  and
enhancement  fee,  which is based on the  number of end users of such  operating
system software,  or a monthly sublicense fee, which is based upon the number of
customers  to  which  the  Company's  products  (which  includes  such  licensed
operating  system  software)  are licensed.  Although the Company  believes that
there  are  alternatives  to the  operating  system  software  that the  Company
currently  uses,  termination  of any of these  licenses could delay the Company
from producing its products for approximately three to six months as a result of
the need to  revise  the  Company's  software  to make it  compatible  with such
alternative operating system software. Such result would have a material adverse
effect on the Company.

         13.  Challenges  to  Management  of Growth.  The Company  anticipates a
period of rapid  growth  that is  expected  to place a strain  on the  Company's
administrative,  financial and operational  resources.  The Company's ability to
manage  any  growth  effectively  will  require it to  continue  to improve  its
operational,   financial  and  management   controls,   reporting   systems  and
procedures,  install new management  information and control systems, and train,
motivate and manage its  employees.  There can be no assurance  that the Company
will install such management information and control systems in an efficient and
timely  manner or that the new systems will be adequate to support the Company's
operations.  Because of the  complexity of its products,  the Company has in the
past  experienced,  and expects in the future to experience,  a time lag between
the date on which  technical and sales personnel are hired and the time at which
such persons become fully productive.  In addition,  customer satisfaction could
be substantially affected by the quality of the Company's

                                      A-11

<PAGE>



post-sales system implementation process and, in many cases, its maintenance and
service  capabilities.  If the  Company  is  unable to hire,  train  and  retain
qualified  personnel and consultants to implement these services or is unable to
manage the post-sales process  effectively,  its ability to attract repeat sales
or obtain references for new prospective sales could be adversely affected. Such
result could limit the Company's growth opportunities. Additionally, many of the
challenges of growth may be unforeseeable and beyond the control of the Company.
If the Company is unable to manage growth  effectively,  such that the Company's
sales and marketing  efforts  exceed its capacity to design,  develop,  install,
maintain and service its  products,  or if new  employees  are unable to achieve
adequate  performance  levels,  the Company's  business,  operating  results and
financial condition could be adversely affected.

         14. Unascertainable Risks Related to Possible Unspecified Acquisitions.
The Company  intends to explore  opportunities  to add,  through  acquisition or
licensing, technology or products to enhance or add to its current product line,
or to acquire a customer  base or sales  organization  to augment the  Company's
infrastructure.  The Company is not  actively  seeking any  acquisition  at this
time.  Although the Company  anticipates it will follow certain general criteria
in determining  whether or not to pursue any acquisition or license,  management
will have sole discretion over whether or not to engage in any such transaction.
There can be no assurance  that the Company will  identify  any  acquisition  or
licensing  candidates  or,  if it  does,  that it will  be  able  to  reach  any
agreements to acquire or license  technology or products,  or acquire assets, on
terms  acceptable  to the  Company.  Since the  Company has not  identified  any
potential acquisition candidates,  there is no basis for the Company to evaluate
the possible  merits or risks  relating to the technology or assets which may be
acquired. To the extent that the Company effects an acquisition of technology or
products in the early stage of  development or growth  (including  technology or
products  which have not been fully  tested or  marketed),  the Company  will be
subject to numerous risks inherent in developmental technology and an additional
high  level  of  risk  associated  with  high-technology   industries  based  on
innovative   technologies   or  processes.   Furthermore,   future   acquisition
transactions may require the Company to obtain  additional  financing from banks
or other  financial  institutions or to undertake debt or equity  financing.  No
assurance can be given that the Company would be able to obtain  financing  upon
commercially  reasonable  terms, or at all.  Furthermore,  equity financing will
result in a dilution  of  existing  shareholders  of the  Company,  which may be
significant. If debt financing ultimately proves to be available, any borrowings
may subject  the  Company to various  risks  traditionally  associated  with the
incurring of indebtedness, including the risks of interest rate fluctuations and
insufficiency of cash flow to pay principal and interest. To the extent any such
transaction  involves the  acquisition of a business,  there can be no assurance
that the Company will  successfully  integrate  the  operations  of the acquired
business  with those of the Company,  or that all of the benefits  expected from
such  integration  will be realized.  Any delays or unexpected costs incurred in
connection  with such  integration  could have an adverse effect on the combined
company's business, operating results or financial condition. Furthermore, there
can be no  assurance  that  the  operations,  management  and  personnel  of the
companies will be compatible or that the Company will not experience the loss of
key  personnel.  In most cases,  each  acquisition  may be  consummated  without
seeking and obtaining shareholder approval, in which case, the shareholders will
not have an opportunity to review the financial statements of an acquisition

                                      A-12

<PAGE>



candidate.  Although the Company will endeavor to evaluate the risks inherent in
a  particular  acquisition,  there can be no  assurance  that the  Company  will
properly ascertain or assess such significant risk factors.

         15.  International  Expansion.  As part  of the  Company's  long  range
marketing plan, the Company intends, in the future, to explore  opportunities to
expand its operations into international markets which could require significant
management  attention and financial  resources.  Currently,  the Company has not
developed any international  marketing  strategy,  has not given any significant
attention to international  marketing, and has no timetable in mind to implement
an international  marketing plan. For the foreseeable  future,  the Company does
not expect  international  marketing  activities to be material nor does it have
any current plans to devote  significant  capital or resources to  international
marketing.  There can be no  assurance  that the  Company's  efforts  to develop
international sales and support channels will be successful. International sales
are subject to a number of risks,  including  potentially longer payment cycles,
unexpected changes in regulatory  requirements,  import and export  restrictions
and  tariffs,  difficulties  in staffing and managing  foreign  operations,  the
burden of  complying  with a variety  of foreign  laws,  greater  difficulty  in
accounts receivable collection,  potentially adverse tax consequences,  currency
fluctuations and potential political and economic instability. Additionally, the
protection of intellectual  property may be more difficult and costly to enforce
outside of the United  States.  In the event that the Company is  successful  in
expanding its sales and operations internationally, the imposition of, or change
in, price controls or other  restrictions on foreign currencies could materially
affect the Company's business, operating results and financial condition.

         16. Control by Existing Management and Shareholders;  Effect of Certain
AntiTakeover  Considerations.  The Company's  directors,  executive officers and
certain   principal   shareholders   and  their   affiliates  own   beneficially
approximately 44.6% of the outstanding Common Shares. Accordingly, such holders,
if acting  together,  have the ability to exert  significant  influence over the
election of the Company's Board of Directors and other matters  submitted to the
Company's  shareholders  for  approval.  The voting  power of these  holders may
discourage  or prevent any  proposed  takeover  of the Company  unless the terms
thereof are approved by such holders.  Pursuant to the Company's  Certificate of
Incorporation,  preferred  shares  may be issued by the  Company  in the  future
without  shareholder  approval and upon such terms as the Board of Directors may
determine.  The rights of the  holders of Common  Shares will be subject to, and
may be adversely  affected by, the rights of the holders of any preferred shares
that may be issued in the future.  The issuance of  preferred  shares could have
the effect of  discouraging  a third  party  from  acquiring  a majority  of the
outstanding  Common  Shares of the  Company  and  preventing  shareholders  from
realizing a premium on their Common Shares.  The  Certificate  of  Incorporation
also provides for staggered  terms for the members of the Board of Directors.  A
staggered Board of Directors,  and certain  provisions of the Company's  by-laws
and of Delaware law  applicable to the Company  (which law prohibits the Company
from engaging in a "business combination" with an "interested shareholder" for a
period of three  years  after the date of the  transaction  in which the  person
became an interested shareholder, unless it is approved in a prescribed manner),
could  delay or make more  difficult  a merger,  tender  offer or proxy  contest
involving the Company.

                                      A-13

<PAGE>



         17.  Impact of Revised  Nasdaq  SmallCap  Market  Rules.  The Company's
Common  Shares are currently  traded on the Nasdaq  SmallCap  Market.  In August
1997,  the  Nasdaq  Stock  Market,  Inc.  adopted a rule  change  which  imposes
substantially more stringent criteria for the continued listing of securities on
the Nasdaq  SmallCap  Market.  The new rules,  which take effect on February 22,
1998,  provide that,  for continued  listing on the Nasdaq  SmallCap  Market,  a
company will need to have, among other things, (i) either net tangible assets of
$2,000,000, a market capitalization of $35,000,000, or net income for two of the
last three fiscal years of $500,000,  and (ii) a minimum  market value of public
float of $1,000,000.  Additionally,  companies will be required to have at least
two independent directors,  and an Audit Committee, a majority of the members of
which will need to be independent directors.

     If the  Company  is  unable  to  satisfy  the  requirements  for  continued
quotation  on the Nasdaq  SmallCap  Market,  trading,  if any, in the  Company's
Common  Shares  would be  conducted  in the  over-the-counter  market in what is
commonly referred to as the "pink sheets" or on the NASD OTC Electronic Bulletin
Board. As a result,  a purchaser of the Common Shares offered hereby may find it
more difficult to dispose of, or to obtain  accurate  quotations as to the price
of,  such  securities.  The  above-described  rules  may  adversely  affect  the
liquidity  of the market for the  Company's  securities.  In any event,  because
certain  restrictions  may be placed upon the sale of securities at prices under
$5.00 per share,  if the price of the Common Shares falls below such  threshold,
unless such Common Shares qualify for an exemption from the "penny stock" rules,
such as continued  listing on the Nasdaq SmallCap  Market,  some brokerage firms
will not effect transactions in the Company's securities and it is unlikely that
any bank or financial  institution  will accept such  securities as  collateral.
Such factors could have a material  adverse  affect in sustaining any market for
the Common Shares.

         18. Securities Market Factors.  In recent years, the securities markets
have  experienced a high level of volume  volatility  and market prices for many
companies,  particularly small and emerging growth companies,  have been subject
to wide fluctuations in response to quarterly  variations in operating  results.
The securities of many of these companies,  which trade in the  over-the-counter
market,  have  experienced  wide  price  fluctuations,  which in many cases were
unrelated to the operating  performance  of, or  announcements  concerning,  the
issuers of the affected stock.  Factors such as  announcements by the Company or
its  competitors   concerning   technological   innovations,   new  products  or
procedures,  government  regulations and  developments  or disputes  relating to
proprietary rights may have a significant impact on the market for the Company's
securities.  General  market price  declines or market  volatility in the future
could adversely affect the future price of the Company's securities.

         19.  "Penny  Stock"  Regulations  May Impose  Certain  Restrictions  on
Marketability  of  Securities.  The  Commission  has adopted  regulations  which
generally define "penny stock" to be any equity security that has a market price
of less than $5.00 per share,  subject to  certain  exceptions.  At the  present
time,  the Common  Shares  offered  hereby are  authorized  for quotation on the
Nasdaq  SmallCap  Market;   therefore,  such  securities  are  exempt  from  the
definition of "penny  stock".  If the Common Shares  offered  hereby are removed
from listing on the Nasdaq SmallCap Market at any

                                      A-14

<PAGE>



time,  however,  the Company's  Common  Shares may become  subject to rules that
impose additional sales practice  requirements on broker-dealers  that sell such
securities to persons other than established  customers and accredited investors
(generally  those with assets in excess of $1,000,000 or annual income exceeding
$200,000,  or $300,000 together with their spouse).  For transactions covered by
these rules, the broker-dealer must make a special suitability determination for
the  purchase of such  securities  and have  received  the  purchaser's  written
consent  to  the  transaction  prior  to the  purchase.  Additionally,  for  any
transaction  involving  a penny  stock,  unless  exempt,  the rules  require the
delivery,  prior to the transaction,  of a risk disclosure  document mandated by
the Commission  relating to the penny stock market.  The broker-dealer must also
disclose the  commission  payable to both the  broker-dealer  and the registered
representative,  current quotations for the securities and, if the broker-dealer
is the sole market  maker,  the  broker-dealer  must  disclose this fact and the
broker-dealer's  presumed control over the market.  Finally,  monthly statements
must be sent disclosing recent price information for the penny stock held in the
account and information on the limited market in penny stocks. Consequently, the
"penny  stock"  rules may  restrict  the ability of  broker-dealers  to sell the
Company's  Common  Shares  and may  affect the  ability  of  purchasers  in this
offering to sell the Company's  Common Shares in the secondary market as well as
the price at which such purchasers can sell any such Common Shares.

         20. No  Dividends.  The  Company  has never paid any  dividends  on its
Common  Shares and does not intend to pay  dividends on its Common Shares in the
foreseeable   future.  Any  earnings  which  the  Company  may  realize  in  the
foreseeable  future are  anticipated to be retained to finance the growth of the
Company.

         21.  Common Shares  Eligible for Future Sale May  Adversely  Affect the
Market. Of the Company's  outstanding  Common Shares,  1,189,400 are "restricted
securities"  and, in the future,  may be sold upon  compliance  with Rule 144 or
pursuant to  registration  under the 1933 Act. Rule 144 currently  provides,  in
essence, that a person holding "restricted  securities" for a period of one year
may  sell an  amount  every  three  months  up to the  greater  of (a) 1% of the
Company's  issued and outstanding  securities of that class of securities or (b)
the average weekly volume of sales of such  securities  during the four calendar
weeks  preceding  the sale if  there  is  adequate  current  public  information
available  concerning the Company.  Additionally,  non-affiliates  (who have not
been  affiliates  of the  Company  for at least  three  months)  may sell  their
"restricted  securities" in compliance with Rule 144 without volume  limitations
after they have held such  securities for a period of two years. An aggregate of
406,250 and 233,000 Common Shares have been owned by Messrs.  Lew and Honigsfeld
for more than one year. However,  such Common Shares are subject to an agreement
restricting  the public sale thereof for a period of one year without consent of
the  underwriter of the Company's  initial public  offering which closed on June
16, 1997.

     The Company is registering  under the registration  statement of which this
Prospectus  is a part the issuance of 1,860,050  Common Shares that are issuable
to certain  shareholders upon the exercise of options granted,  and which may be
granted,  under the  Plans,  and the resale  (pursuant  to this  Prospectus)  of
2,750,000  Common Shares  issued,  or which may be issued,  upon the exercise of
options granted under the Plans to certain persons who may be deemed  affiliates
of the Company.

                                      A-15

<PAGE>



In addition,  the Company previously registered for resale 509,200 Common Shares
underlying certain warrants. Of such 509,200 Common Shares, 120,000 are issuable
upon the exercise of warrants  commencing  on June 10, 1998 and may be resold at
any  time  thereafter,  and  389,200  may be  resold  at any  time,  subject  to
restrictions  on  transfer  for a  period  of two  years  from  June  10,  1997.
Prospective  investors  should be aware that the possibility of resales by other
shareholders of the Company may have a material  depressive effect on the market
price of the Company's Common Shares in any market which may develop.

         22.  Limitations on Director  Liability.  The Company's  Certificate of
Incorporation provides, pursuant to Delaware law, that a director of the Company
shall not be personally  liable to the Company or its  shareholders for monetary
damages for breach of fiduciary  duty as a director,  with  certain  exceptions.
These  provisions  may  discourage  shareholders  from  bringing  suit against a
director  for  breach  of  fiduciary  duty  and may  reduce  the  likelihood  of
derivative  litigation  brought by shareholders on behalf of the Company against
any director. In addition,  the Company's Certificate of Incorporation  provides
for mandatory  indemnification  of directors and officers to the fullest  extent
permitted or not prohibited by Delaware law.

                                SUBSEQUENT EVENTS

         On July 18,  1997,  John P.  Hefferon  resigned as the  Executive  Vice
President -- Sales and Marketing.  The Company has not replaced Mr.  Hefferon at
this time, and it is currently searching for an appropriate candidate.  Although
the Company  expects to  identify  and secure a  qualified  replacement  for Mr.
Hefferon,  there can be no  assurance  that such a person will be engaged by the
Company in the near future or at all.

                              SELLING SHAREHOLDERS

     The  following  table sets forth,  as of October 24, 1997, to the Company's
knowledge,  certain securities ownership information with respect to the Selling
Shareholders:
<TABLE>

                                                                                           Common Shares to
                                       Common Shares              Number of Common         be Beneficially
                                    Beneficially Owned             Shares Offered            Owned After
          Name                      Before Offering(1)              for Sale                 Offering
<S>       <C>                      <C>                            <C>                    <C>        <C>

                                                                                                     Percent of
                                                                                         Number      Outstanding

         Mark Honigsfeld                  623,200(2)               333,000(3)            390,200        14.1%
         Dong W. Lew                      566,200                  156,950               409,250        14.5%
         Louis Libin                          0                     50,000(4)               0            --
         William D. Rizzardi                5,000 (5)                5,000(4)              5,000(5)       *
         Harold Lazarus                                              5,000(4)               0             --
</TABLE>

- ----------------
*less than one percent
(1)      Unless  otherwise  noted,  the Company  believes that all persons named
         above have sole voting and investment  power with respect to all Common
         Shares  beneficially owned by them, subject to community property laws,
         where applicable. A person is deemed to be the

                                      A-16

<PAGE>



         beneficial  owner of  securities  that can be  acquired  by such person
         within 60 days from September 30, 1997 upon the exercise of warrants or
         options.  Each beneficial owner's percentage ownership is determined by
         assuming that options or warrants that are held by such person (but not
         those held by any other  person)  and which are  exercisable  within 60
         days from September 30, 1997 have been exercised.

(2)      423,200  Common  Shares are held by the Mark  Honigsfeld  Living  Trust
         dated March 27, 1996 (the "Honigsfeld Trust") whose sole beneficiary is
         Mr.  Honigsfeld's wife. Mr. Honigsfeld,  the settlor and trustee of the
         Honigsfeld  Trust,  has the right to terminate the Honigsfeld Trust and
         receive the Common Shares. 200,000 Common Shares are held by the Mardee
         Charity Fund Foundation (the "Foundation").  Mr. Honigsfeld is the sole
         trustee of the Foundation.

(3)      Includes  100,000  Common Shares  issuable upon the exercise of options
         granted under the 1996 Plan,  which options are not exercisable  within
         60  days  from  September  30,  1997.  Since  such  options  are not so
         exercisable,  the  underlying  Common  Shares are not  included  within
         "Common Shares Beneficially Owned Before Offering."

(4)      Represents  Common Shares issuable upon the exercise of options granted
         under the 1996 Plan,  which options are not exercisable  within 60 days
         from September 30, 1997. Since such options are not so exercisable, the
         underlying  Common  Shares  are  not  included  within  "Common  Shares
         Beneficially Owned Before Offering."

(5) Does not include Common Shares described in footnote 4.

                   There are no  commitments  pursuant to which the Company will
receive  any  proceeds  from  the  sale  of the  Common  Shares  by the  Selling
Shareholders.

                  To the Company's knowledge, no Selling Shareholder has had any
position,  office or other material  relationship with the Company or any of its
affiliates  during the past three years (other than as a holder of the Company's
securities), except that (i) Mr. Honigsfeld has served as Chairman of the Board,
Chief  Executive  Officer and Secretary of the Company since 1996;  (ii) Mr. Lew
has served as a director of the Company and President of the Company since 1992,
and has served as  Treasurer  of the  Company  since 1996;  (iii) Mr.  Libin has
served as director of the  Company and Chief  Technology  Officer of the Company
since  January 1997;  (iv) Mr.  Rizzardi has served as a director of the Company
since January 1997;  and (v) Dr. Lazarus has served as a director of the Company
since March 1997.







                                      A-17

<PAGE>



                              PLAN OF DISTRIBUTION

     The Common Shares set forth in the "Selling Shareholders" table may be sold
by the  Selling  Shareholders,  or by  pledgees,  donees,  transferees  or other
successors in interest,  either pursuant to the Registration  Statement of which
this  Prospectus  forms a part or, if available,  under Section 4(1) of the 1933
Act or Rule 144 promulgated thereunder.

     To the Company's  knowledge,  this offering is not being underwritten.  The
Company  believes  that  the  Selling  Shareholders,   directly  through  agents
designated from time to time, or through  broker-dealers or underwriters also to
be designated  (who may purchase as principal and resell for their own account),
may sell the Common Shares from time to time, in or through privately negotiated
transactions,  or in one or more transactions,  including block transactions, on
the Nasdaq SmallCap Market or on any other market or stock exchange on which the
Common Shares may be listed in the future pursuant to and in accordance with the
applicable  rules of such market or exchange or otherwise.  The selling price of
the Common  Shares may be at market  prices  prevailing  at the time of sale, at
prices relating to such prevailing market prices or at negotiated  prices.  From
time  to  time,  to  the  extent   permitted  by  applicable  law,  the  Selling
Shareholders may engage in short sales against the box, puts and calls and other
transactions in securities of the Company or derivatives  thereof,  and may sell
and deliver the Common  Shares in  connection  therewith.  Further,  except as a
result of limitations imposed on the Selling  Shareholders  pursuant to Form S-8
General Instruction  C(2)(b),  and as set forth herein, the Selling Shareholders
are not  restricted  as to the number of Common  Shares which may be sold at any
one time, and it is possible that a significant number of Common Shares could be
sold at the same time, which may have a depressive effect on the market price of
the Company's Common Shares.

     The Selling  Shareholders  may also pledge Common Shares as collateral  for
margin accounts, and such Common Shares could be resold pursuant to the terms of
such  accounts.  Resales  or  reoffers  of the  Common  Shares  by  the  Selling
Shareholders must be accompanied by a copy of this Prospectus.

     The Selling  Shareholders  and any agents,  broker-dealers  or underwriters
that  participate in the  distribution  of the Common Shares may be deemed to be
underwriters,  and any profit on the sale of the Common Shares by them,  and any
discounts,  commissions  or  concessions  received by them,  may be deemed to be
underwriting commissions or discounts under the 1933 Act.

     The Common Shares offered for resale herein for the accounts of each of the
Selling Shareholders are subject,  among other things, to an agreement with E.C.
Capital, Ltd. ("E.C.  Capital") and the Company imposing certain restrictions on
public sale thereof until June 10, 1998.



                                      A-18

<PAGE>



                                  LEGAL MATTERS

     Matters relating to the legality of the securities being offered hereby are
being  passed upon for the  Company by  Certilman  Balin Adler & Hyman,  LLP, 90
Merrick Avenue, East Meadow, New York 11554.

                                     EXPERTS

     The financial statements of the Company as of December 31, 1996 and for the
years ended December 31, 1996 and 1995 included in the Prospectus forming a part
of the Form SB-2  Registration  Statement  have been  audited by Lazar  Levine &
Company,  LLP, independent  certified public accountants,  as set forth in their
report thereon appearing therein and are incorporated herein by reference to the
Form SB-2  Registration  Statement  in reliance  upon such report given upon the
authority of such firm as experts in accounting and auditing.

                             ADDITIONAL INFORMATION

     The Company has filed a  Registration  Statement on Form S-8 (together with
all amendments thereto, the "Registration  Statement") with the Commission under
the 1933 Act with respect to the securities offered hereby. This Prospectus does
not contain all of the information set forth in the Registration Statement.  For
further  information  with  respect to the  Company and the  securities  offered
hereby,  reference  is made to the  Registration  Statement  and to the exhibits
filed  therewith,  copies  of  which  may  be  obtained  upon  payment  of a fee
prescribed  by the  Commission,  or may be examined free of charge at the public
reference facilities  maintained by the Commission at Judiciary Plaza, 450 Fifth
Street,  N.W.,  Washington,  D.C. 20549.  Each statement made in this Prospectus
referring  to a document  filed as an exhibit to the  Registration  Statement is
qualified by reference to the exhibit for a complete  statement of its terms and
conditions.


                                      A-19

<PAGE>



                                INDEX TO EXHIBITS


Exhibit           Description
Number            of Exhibit

   4.1            Specimen Common Stock Certificate(1)

   5              Opinion  of  Certilman  Balin  Adler & Hyman,  LLP as to the
                  legality of the Common Shares issuable  pursuant to the 1996
                  Plan and the 1997 Plan and being registered hereunder

  10.1            1996 Stock Option Plan(1)

  10.2            1997 Qualified Employee Stock Purchase Plan, as amended

  23.1            Consent of Lazar Levine & Company, LLP

  23.2            Consent of Certilman Balin Adler & Hyman, LLP (included in its
                  opinion filed as Exhibit 5)

  24              Powers of Attorney (included in signature page forming a part
                  hereof)


















- --------------------

          (1) Denotes  document  filed as an exhibit to the Company's  Form SB-2
Registration  Statement (File No.  333-18667)  which is  incorporated  herein by
reference thereto.




                                                                      EXHIBIT 5




                                October 31, 1997



Compu-DAWN, Inc,
77 Spruce Street
Cedarhurst, New York 11516

                   Re:  Registration of 2,360,050 Common Shares,
                        par value $.01 per share, under the
                        Securities Act of 1933, as amended

Gentlemen:

     In our capacity as counsel to Compu-DAWN, Inc., a Delaware corporation (the
"Company"),  we have been  asked to render  this  opinion in  connection  with a
Registration Statement on Form S-8 being filed contemporaneously herewith by the
Company with the Securities and Exchange  Commission under the Securities Act of
1933, as amended (the "Registration  Statement"),  covering, among other things,
the  issuance of an aggregate of  2,360,050  Common  Shares,  par value $.01 per
share, of the Company (the "Common Shares") that may be issued upon the exercise
of options to acquire  Common  Shares  granted  under the  Company's  1996 Stock
Option Plan and 1997 Qualified Employee Stock Purchase Plan  (collectively,  the
"Plans").

     In that connection,  we have examined the Certificate of Incorporation  and
the ByLaws of the Company,  each as amended, the Registration  Statement and the
Plans and are familiar with corporate proceedings of the Company relating to the
adoption of each of the Plans. We have also examined such other  instruments and
documents as we deemed relevant under the circumstances.

     For  purposes of the  opinions  expressed  below,  we have  assumed (i) the
authenticity of all documents  submitted to us as original,  (ii) the conformity
to the  originals  of all  documents  submitted  as  certified,  photostatic  or
facsimile copies and the authenticity of the originals, (iii) the legal capacity
of natural persons,  (iv) the due  authorization,  execution and delivery of all
documents by all parties and the validity and binding effect thereof and (v) the
conformity to the  proceedings  of the Board of Directors of all minutes of such
proceedings.  We have also assumed that the corporate records furnished to us by
the Company include all corporate proceedings taken by the Company to date.





<PAGE>


Compu-DAWN, Inc.
October 31, 1997
Page 2

     Based upon and subject to the  foregoing,  we are of the  opinion  that the
Common  Shares have been duly and validly  authorized  and, when issued and paid
for as described in each of the Plans,  will be duly and validly  issued,  fully
paid and nonassessable.

     We hereby  consent  to the use of our  opinion  as  herein  set forth as an
exhibit to the Registration Statement.

     This opinion is as of the date hereof, and we do not undertake,  and hereby
disclaim,  any obligation to advise you of any changes in any of the matters set
forth herein.

     We are  rendering  this opinion only as to the matters  expressly set forth
herein, and no opinion should be inferred as to any other matters.

     This  opinion  is for your  exclusive  use only and is to be  utilized  and
relied upon only in connection with the matters expressly set forth herein.


                                      Very truly yours,



                                     /s/ Certilman Balin Adler & Hyman, LLP
                                     CERTILMAN BALIN ADLER & HYMAN, LLP



- -------------------------------------------------------------------------------


                                    * * * * *

                   1997 QUALIFIED EMPLOYEE STOCK PURCHASE PLAN

                                       OF

                                COMPU-DAWN, INC.

                      (As amended through October 21, 1997)

                                    * * * * *

- -------------------------------------------------------------------------------






<PAGE>


<TABLE>

                   1997 QUALIFIED EMPLOYEE STOCK PURCHASE PLAN

                                       OF

                                COMPU-DAWN, INC.
                      (As Amended through October 21, 1997)

<CAPTION>
                                TABLE OF CONTENTS

<S>     <C>    
                                                                                                      <C>
1.       Designation and Purpose of the Plan .............................................................1

2.       Shares Reserved for the Plan ....................................................................1

3.       Administration of the Plan ......................................................................2
         (a)      General ................................................................................2
         (b)      Committee Procedures ...................................................................2
         (c)      Authority over the Plan ................................................................2
         (d)      Changes in Law Applicable ..............................................................3

4.       Eligibility and Participation in Plan ...........................................................3
         (a)      Eligible Employees .....................................................................3
         (b)      Election to Participate ................................................................3
         (c)      Restrictions on Participation ..........................................................4
         (d)      Rights and Privileges of Participating Employees ...................................... 4

5.       Term ............................................................................................4

6.       Method of Granting and Exercising Stock Options ................................................ 4
         (a)      Grant of Option ........................................................................4
         (b)      Option Period ..........................................................................5
                  (1)      General .......................................................................5
                  (2)      Termination of Option Upon Retirement, Death or Termination
                           of Employment .................................................................5
         (c)      Option Purchase Price ..................................................................6
                  (1)      Purchase Price ................................................................6
                  (2)      Determination of Fair Market Value ............................................6
         (d)      Exercise of Options ....................................................................7
         (e)      Nontransferability of Options and Rights ...............................................7
         (f)      Compliance with Securities Laws ........................................................7

7.       Medium and Time of Payment ......................................................................9
         (a)      Payroll Deductions .....................................................................9
         (b)      Authorization ..........................................................................9

                                                         i

<PAGE>



         (c)      Amount of Deduction ....................................................................9
         (d)      Account of Participating Employee ......................................................10
         (e)      No Changes in Payroll Deductions .......................................................10
         (f)      Termination and Withdrawal of Payroll Deductions .......................................10
         (g)      Effect on Participation ................................................................10
         (h)      Termination of Employment ..............................................................11
         (i)      No Payment of Interest .................................................................11
         (j)      Use of Funds ...........................................................................11

8.       Issuance and Delivery of Common Shares ..........................................................11

9.       Participating Employee's Rights as Stockholder ..................................................11

10.      Participating Employee's Agreement to Serve .....................................................12

11.      Adjustments on Changes in Capitalization ........................................................12
         (a)      Changes in Capitalization ..............................................................12
         (b)      Reorganization, Dissolution or Liquidation .............................................13
         (c)      Change in Par Value ....................................................................13
         (d)      Notice of Adjustments ..................................................................13
         (e)      Effect Upon Holder of Option ...........................................................14
         (f)      Right of Company to Make Adjustments ...................................................15

12.      Amendment of the Plan ...........................................................................15

13.      Termination of the Plan .........................................................................16

14.      Effective Date of Plan ..........................................................................16

15.      Indemnification of Board of Directors or the Committee ..........................................16

16.      Notices .........................................................................................16

17.      Designation of Beneficiary ......................................................................17

18.      Application of Funds ............................................................................17

19.      Approval of Stockholders ........................................................................17

20.      Governing Law ...................................................................................18


</TABLE>

                                       ii

<PAGE>



                   1997 QUALIFIED EMPLOYEE STOCK PURCHASE PLAN

                                       OF

                                COMPU-DAWN, INC.

                      (As Amended through October 21, 1997)


     COMPU-DAWN,  INC. (the "Company"), a Delaware corporation,  has adopted and
established a qualified  employee  stock purchase plan effective May 9, 1997, as
amended  hereby,  for eligible  employees in accordance with the following terms
and conditions:  

     1. Designation and Purpose of the Plan. 

     This plan is designated the "Compu-DAWN Inc. 1997 Qualified  Employee Stock
Purchase  Plan" (the  "Plan").  The purpose of the Plan is to advance the growth
and  development of the Company or any Subsidiary  (as  hereinafter  defined) by
providing an opportunity to all Participating Employees (as hereinafter defined)
to acquire an ownership  interest in the Company.  It is believed  that employee
participation in the ownership of the business will help to achieve the unity of
purpose  essential to the continued growth of the Company and the mutual benefit
of its  employees  and  Stockholders.  The Plan is  intended  to comply with the
provisions of Sections 421, 423 and 424 of the Internal Revenue Code of 1986, as
amended  (the  "Code"),  and the Plan  shall be  administered,  interpreted  and
construed  in  accordance  with  such  provisions.  As  used  herein,  the  term
Subsidiary or Subsidiaries  shall mean any corporation  (other than the employer
corporation)  in an unbroken chain of  corporations  beginning with the employer
corporation if, at the time of a stock option,  each of the  corporations  other
than the last  corporation  in the unbroken  chain owns stock  possessing  fifty
percent (50%) or more of the total combined voting power of all classes of stock
in one of the other corporations in such chain.

     2. Shares  Reserved  for the Plan.  

     Subject to  adjustments  as provided  in Section 11 hereof,  there shall be
reserved for issuance and purchase by participating  Employees under the Plan an
aggregate of Two Hundred and Fifty Thousand  (250,000) common shares,  $0.01 par
value, of the Company (the "Common Shares"),  which Common Shares in whole or in
part either shall be authorized,  but unissued,  Common Shares, or issued Common
Shares which shall have been  reacquired by the Company as determined  from time
to time by the Board of Directors of the

                                        1

<PAGE>



Company (the "Board of Directors").

         3.       Administration of the Plan.

                 (a) General. The plan shall be administered, at the expense of
         the  Company,  by the Board of  Directors of the Company (the "Board of
         Directors")  or by a  committee  chosen by the Board of  Directors  who
         shall serve at the pleasure of the Board of  Directors  and which shall
         be designated as the  Compensation  Committee  (the  "Committee").  

               (b) Committee Procedures. If the Board of Directors determines to
          choose a Committee to administer  the Plan, the Board of Directors may
          from time to time appoint members of the Committee in substitution for
          or in addition to members previously appointed and may fill vacancies,
          however caused,  in the Committee.  If the Board of Directors does not
          designate a Chairman of the Committee,  the Committee shall select one
          of its members as its Chairman.  The Committee  shall hold meetings at
          such times and places at it may  determine.  A majority of its members
          shall constitute a quorum.  Any action of the Committee shall be taken
          by a  majority  vote of its  members at a meeting at which a quorum is
          present.  Notwithstanding  the preceding,  any action of the Committee
          may be taken without a meeting by a written  consent  signed by all of
          the  members,  and any  action  so  taken  shall  be  deemed  fully as
          effective as if it had been taken by a vote of the members  present in
          person at a meeting duly called and held.  The Committee may appoint a
          Secretary, and shall keep minutes of its meetings, and shall make such
          rules and regulations for the conduct of its business as it shall deem
          advisable.  The Committee  may request  advice or assistance or employ
          such other persons as are necessary for proper  administration  of the
          Plan.  

               (c)  Authority  over the  Plan.  The  Board of  Directors  or the
          Committee,  as the case may be,  shall  have  the sole  authority  and
          power,  subject to the express provisions and limitations of the Plan,
          to construe the Plan and to adopt, prescribe,  amend and rescind rules
          and  regulations   relating  to  the  Plan,  and  to  make  all  other
          determinations  necessary or  advisable  for  administering  the Plan;
          provided,  however, that the Board of Directors or the Committee shall
          at  all  times  administer  the  Plan  and  make   determinations  and
          interpretations  hereunder such that the Plan is a qualified  employee
          stock  purchase plan within the meaning of Sections 421 and 423 of the
          Code. All determinations of the Board of Directors or the

                                        2

<PAGE>



         Committee,  as the case may be,  shall be final  and  binding  upon all
         persons,  and in  the  case  where  the  Plan  is  administered  by the
         Committee,  unless otherwise  determined by the Board of Directors.  No
         member of the Board of Directors or the  Committee  shall be liable for
         any action or determination made in good faith with respect to the Plan
         or any  Option  granted  under  it.  In the  case  where  the  Plan  is
         administered  by the Committee,  upon issuing an Option under the Plan,
         the  Committee  shall report to the Board of Directors  the name of the
         Participating  Employee  granted  the  Option,  the number of shares of
         Common  Shares  covered by the Option and the terms and  conditions  of
         such Option.

                  (d)  Changes  in Law  Applicable.  If  the  laws  relating  to
         qualified  stock purchase plans are changed,  altered or amended during
         the term of the Plan, the Board of Directors  shall have full authority
         and power to alter or amend the Plan to conform to such  changes in the
         law without the necessity of obtaining  further  stockholder  approval,
         unless  the  changes   require  such  approval.   

     4.   Eligibility  and Participation in Plan.

                  (a)  Eligible  Employees.  Any employee who is employed by the
         Company or a  Subsidiary  on any  January 1 during the term of the Plan
         (each a  "Commencement  Date") is eligible to  participate  in the Plan
         with respect to the particular year provided such employee:

                         (1) has been  employed by the  Company or a  Subsidiary
                    for at least one (1) year  prior to the  Commencement  Date,
                    and

                         (2) has  customary  employment of more than twenty (20)
                    hours per week,  and has  customary  employment  of at least
                    five (5) months in such calendar year.

         Employees   eligible  to  participate  in  the  Plan  pursuant  to  the
         provisions  of  this  Section  4(a)  are  hereinafter  referred  to  as
         "Eligible Employees".

                  (b) Election to  Participate.  Each Eligible  Employee on each
         Commencement  Date may participate in the Plan by filing with the Board
         of Directors,  the  Committee,  or such other person  designated by the
         Board of Directors or the  Committee at least thirty (30) days prior to
         each such Commencement  Date a Participation  Election Form which shall
         be  distributed  by the Board of  Directors  or the  Committee  to each
         Eligible  Employee  at  least  thirty-five  (35)  days  prior  to  each
         Commencement Date. Eligible Employees who elect to

                                        3

<PAGE>



          participate in the Plan as provided above are hereinafter  referred to
          as "Participating Employees".

                  (c)  Restrictions  on   Participation.   Notwithstanding   any
         provision of the Plan to the contrary, no Participating Employee may be
         granted an Option under the Plan:

                           (1)   if,   immediately   after   the   grant,   such
                  Participating  Employee would own Common  Shares,  and/or hold
                  outstanding Options to purchase Common Shares, possessing five
                  percent  (5%) or more of the total  combined  voting  power or
                  value of all  classes  of  capital  stock of the  Company.  In
                  determining stock ownership under this Section 4(c), the stock
                  attribution  rules of Section  424(d) of the Code shall apply,
                  and Common  Shares which the  employee may purchase  under any
                  outstanding  options,  whether or not such options qualify for
                  the special tax  treatment  afforded by Section  421(a) of the
                  Code, shall be treated as Common Shares owned by the employee;
                  or

                           (2)  which  permits  such  Participating   Employee's
                  rights to purchase stock of any class or description under all
                  employee stock  purchase  plans of the Company  (previously or
                  hereafter  adopted) to which  Section 423 of the Code applies,
                  to accrue at a rate which exceeds Twenty-Five Thousand Dollars
                  ($25,000)  (or such other  maximum as may be  prescribed  from
                  time to time by the Code) of fair  market  value of such stock
                  (determined  at the time  such  Option  is  granted)  for each
                  calendar year in which such Option is outstanding at any time.
                  For  purposes  of this  Section  4(c),  the  rules of  Section
                  423(b)(8) of the Code shall apply in  determining  the accrual
                  rate of a  Participating  Employee's  rights to purchase  such
                  stock. 

               (d)  Rights  and  Privileges  of  Participating   Employees.  All
          Participating  Employees granted Options under the Plan shall have the
          same rights and  privileges,  except as otherwise  provided in Section
          4(c)  hereof.  

          5. Term.  The Plan shall  continue in effect from the  Effective  Date
     until all of the Common  Shares  reserved for issuance  under the Plan have
     been issued or until the Plan is  terminated  by the Company,  whichever is
     earlier. 

          6. Method of Granting and Exercising Stock Options.

                                        4

<PAGE>



                  (a) Grant of Option. On the Commencement Date, this Plan shall
         be deemed to have granted to the Participating  Employee an option (the
         "Option") for as many full Common Shares as the Participating  Employee
         will be able to purchase  with the payroll  deductions  credited to the
         Participating  Employee's  account  during a given  Option  Period  (as
         hereinafter  defined) (the "Offering").  Notwithstanding the foregoing,
         no Participating  Employee may purchase more than Five Thousand (5,000)
         Common Shares during any single Offering. If the total number of Common
         Shares for which  Options  are to be granted on any date in  accordance
         with this section  exceeds the number of Common  Shares then  available
         under the Plan (after  deduction of all Common Shares for which Options
         have been exercised or are then outstanding),  the Company shall make a
         pro rata  allocation  of the Common  Shares  remaining  available in as
         nearly  a  uniform  manner  as  shall  be  practicable  and as it shall
         determine to be equitable.  In such event, the payroll deductions to be
         made  pursuant  to  the   authorizations   therefor  shall  be  reduced
         accordingly and the Company shall give written notice of such reduction
         to each employee affected thereby.

                  (b)      Option Period.

                           (1)  General.  The  Option  shall be for a period  of
                  twelve (12) months (the  "Option  Period") and shall be deemed
                  to be  exercised  one year from the date of grant,  subject to
                  earlier termination as provided in Section 6(b)(2) below.

                           (2) Termination of Option Upon  Retirement,  Death or
                  Termination  of Employment.  (i) In the event a  Participating
                  Employee retires or dies, or his employment terminates for any
                  other reason  prior to the  exercise of the Option  granted to
                  such Participating Employee (a "Terminated Employee"), subject
                  to the provisions of Section  6(b)(ii)  below such  Terminated
                  Employee  shall not be  considered  a  Participating  Employee
                  under the Plan after the date such Terminated Employee retires
                  or dies or his  employment  terminates,  and  such  Terminated
                  Employee's rights with respect to any Options granted for such
                  year shall cease and the Option shall be null and void.

                                    (ii)   Notwithstanding   the   provision  of
                  Section  6(b)(2)(i),  the Board of Directors or the Committee,
                  in its sole and absolute discretion, may permit a

                                        5

<PAGE>



                  Terminated   Employee,   upon  the  written  consent  of  such
                  Terminated  Employee,  or  the  representative  of a  deceased
                  Terminated  Employee,  to  be  considered  as a  Participating
                  Employee  for  the  purposes  of  the  Plan  only,  until  the
                  expiration of the Option Period during which the employment of
                  the Terminated  Employee  terminated and until the outstanding
                  Options granted by such Terminated  Participating  Employee at
                  the beginning of such Option Period are deemed exercised.  The
                  provisions of this Section  6(b)(2)(ii) shall not be construed
                  as granting the  Terminated  Employee any right to be retained
                  in the  employ  of  the  Company  or  Subsidiary. 

               (c) Option Purchase Price.

         (1)  Purchase  Price.  The  "Option  Purchase  Price" for each share of
Common Shares shall be an amount equal to the lesser of: (i) eighty-five percent
(85%) of the fair market  value of such  Common  Share on the date the Option is
granted,  or (ii)  eighty-five  percent  (85%) of the fair market  value of such
Common Share on the date the Option is exercised.

         (2) Determination of Fair Market Value.  During such time as the Common
Shares of the Company is not listed upon an established stock exchange, the fair
market  value per Common  Share shall be deemed to be the closing  sale price of
the Common  Shares on the Nasdaq Stock  Market,  Inc.  ("Nasdaq") on the day the
Option is granted or exercised,  as  applicable,  as reported by Nasdaq,  if the
Common Shares are so quoted,  and if not so quoted,  the mean between the dealer
"bid" and "ask" prices,  of the Common  Shares in the New York  over-the-counter
market on the day the Option is granted or exercised, as applicable, as reported
by the National Association of Securities Dealers, Inc. If the Common Shares are
listed upon an established  stock exchange or exchanges,  such fair market value
shall be deemed to be the  highest  closing  price of the Common  Shares on such
stock  exchange or exchanges on the day the Option is granted or  exercised,  as
applicable,  or, if no sale of the Common  Shares of the Company shall have been
made on  established  stock  exchange on such day, on the next  preceding day on
which there was a sale of

                                        6

<PAGE>



Common Shares. If there is no market price for the Common Shares, then the Board
of  Directors  or the  Committee  may,  after  taking  all  relevant  facts into
consideration, determine the fair market value of the Common Shares.

                  (d)  Exercise  of Options.  Each  Participating  Employee  who
         continues  to be a  Participating  Employee  one  year  after  a  given
         Commencement  Date shall be deemed to have  exercised the Option on the
         one-year  anniversary of such Commencement Date, and shall be deemed to
         have  purchased  from the Company  such  number of full  Common  Shares
         reserved  for the purpose of the Plan as the  Participating  Employee's
         accumulated  payroll  deduction on such date will pay for at the Option
         price, subject to adjustment as provided in Section 6(a) above.

                  (e)  Nontransferability  of Options  and  Rights.  All Options
         granted  pursuant to this Plan shall be  personal to the  Participating
         Employee  receiving such Options and shall be exercisable  only by such
         Participating  Employee. No Participating Employee shall have the right
         to sell, assign, transfer,  pledge, or otherwise dispose of or encumber
         either such  Participating  Employee's right to participate in the Plan
         or  such  Participating  Employee's  interest  in  the  fund,  if  any,
         accumulated for the benefit of such  Participating  Employee,  and such
         right and  interest  shall not be liable for, or subject to, the debts,
         contracts,  or liabilities of such Participating Employee. No Option or
         any right  thereunder  shall be subject  to  execution,  attachment  or
         similar process or remedy. Upon any attempt to sell, exchange,  assign,
         pledge,  discount,  hypothecate  or otherwise  transfer or encumber any
         Option or any right thereunder or in connection  therewith  contrary to
         or in violation  of the  provisions  of this Plan,  such Option and all
         rights  thereunder  shall  immediately  become  null  and  void and the
         balance of any unused payroll deductions of the Participating  Employee
         then being held by the Company shall be refunded to such  Participating
         Employee without interest.

                  (f) Compliance  with  Securities  Laws. The Plan and the grant
         and exercise of the rights to purchase Common Shares hereunder, and the
         Company's  obligation  to sell  and  deliver  Common  Shares  upon  the
         exercise of rights to purchase  Common Shares,  shall be subject to all
         applicable  federal and state laws, rules and regulations,  and to such
         approvals  by any  regulatory  or  governmental  agency as may,  in the
         opinion of counsel for the

                                        7

<PAGE>



         Company, be required, and shall also be subject to all applicable rules
         and  regulations  of any stock exchange or Nasdaq upon which the Common
         Shares of the  Company may then be listed or quoted as the case may be.
         At the time of  exercise  of any  Option,  the  Company may require the
         Participating  Employee  to execute  any  documents  or take any action
         which may be then  necessary to comply with the Securities Act of 1933,
         as  amended   ("Securities   Act"),   and  the  rules  and  regulations
         promulgated  thereunder,  or any other applicable federal or state laws
         regulating the sale and issuance of securities, and the Company may, if
         it deems  necessary,  include  provisions  in the Option  Agreements to
         assure such compliance.  The Company may, from time to time, change its
         requirements  with  respect to  enforcing  compliance  with federal and
         state  securities  laws,  including the request for and  enforcement of
         letters of investment intent, such requirements to be determined by the
         Company in its  judgment as necessary  to assure  compliance  with said
         laws. Such changes may be made with respect to any particular Option or
         stock issued upon exercise thereof.  Without limiting the generality of
         the  foregoing,  if the Common Shares usable upon exercise of an Option
         granted under the Plan are not registered under the Securities Act, the
         Company at the time of exercise will require that the registered  owner
         execute  and  deliver an  investment  representation  agreement  to the
         Company in form  acceptable  to the  Company and its  counsel,  and the
         Company will place a legend on the  certificate  evidencing such Common
         Shares  restricting  the  transfer  thereof,   which  legend  shall  be
         substantially as follows:

                           THE COMMON  SHARES  REPRESENTED  BY THIS  CERTIFICATE
                           HAVE NOT BEEN REGISTERED  UNDER THE SECURITIES ACT OF
                           1933, AS AMENDED,  OR ANY APPLICABLE STATE SECURITIES
                           LAW BUT HAVE BEEN ACQUIRED FOR THE PRIVATE INVESTMENT
                           OF THE HOLDER HEREOF AND MAY NOT BE OFFERED,  SOLD OR
                           TRANSFERRED UNTIL EITHER (i) A REGISTRATION STATEMENT
                           UNDER SUCH  SECURITIES ACT OR SUCH  APPLICABLE  STATE
                           SECURITIES  LAWS SHALL  HAVE  BECOME  EFFECTIVE  WITH
                           REGARD  THERETO,  OR  (ii)  THE  COMPANY  SHALL  HAVE
                           RECEIVED  AN  OPINION OF  COUNSEL  ACCEPTABLE  TO THE
                           COMPANY AND ITS COUNSEL THAT REGISTRATION  UNDER SUCH
                           SECURITIES ACT OR SUCH  APPLICABLE  STATE  SECURITIES
                           LAWS IS

                                        8

<PAGE>



                           NOT REQUIRED IN CONNECTION WITH SUCH PROPOSED
                           OFFER, SALE OR TRANSFER.

         7.       Medium and Time of Payment.

                  (a)  Payroll  Deductions.  The  purchase  price of the  Common
         Shares as to which the Option shall be exercised  shall be paid in full
         through periodic payroll deductions during the term of the Option.

                  (b)  Authorization.  A Participating  Employee shall authorize
         the Company to make payroll  deductions  from the  compensation of such
         Participating  Employee  by  completing  an  authorization  for payroll
         deduction  on the form  prescribed  by the  Board of  Directors  or the
         Committee and filing it with the Board of Directors,  the Committee, or
         such other person designated by the Board of Directors or the Committee
         at the time such Participating  Employee files a Participation Election
         form with the Board of  Directors  or the  Committee  (as  provided  in
         Section 4(b) hereof).  Payroll deductions for a Participating  Employee
         shall  commence on the  Commencement  Date of the Offering  immediately
         following the date of execution of the payroll deduction  authorization
         form by the Participating Employee and shall end on December 31 of that
         year unless sooner terminated by the Participating Employee as provided
         in  Section  7(f)  hereof.  

               (c) Amount of  Deduction.  At the time a  Participating  Employee
          files an  authorization  for  payroll  deduction,  such  Participating
          Employee shall elect to have deductions  made from such  Participating
          Employee's   compensation  on  each  pay  day  during  the  time  such
          Participating  Employee is a participant in an Offering at the rate of
          one, two, three, four, five, six, seven, eight, nine or ten percent of
          the Regular  Compensation of such Participating  Employee in effect at
          the Commencement Date of the Offering.  For the purposes of this Plan,
          "Regular  Compensation"  shall  mean  the  regular  rate  of  pay of a
          Participating  Employee for the calendar year ending at or immediately
          prior  to  the   Commencement   Date.   In  the  case  of  a  salaried
          Participating Employee,  "Regular Compensation" shall be the amount of
          base salary such salaried employee received during such calendar year.
          In the case of an hourly-paid Participating Employee, "Regular

                                        9

<PAGE>



          Compensation"  shall  be the  hourly  rate of pay of such  hourly-paid
          employee  multiplied by 40 hours for the applicable  one-week  payroll
          period.  In the case of a  Participating  Employee who receives all or
          part of such  Participating  Employee's  compensation  in the  form of
          commissions,  the "Regular  Compensation"  shall be the base salary of
          such   Participating   Employee  plus  a  proportionate  part  of  any
          commissions  or  bonuses  such  Participating  Employee  receives,  as
          determined  by the Board of  Directors or the  Committee  from time to
          time to  reflect  an  equitable  adjustment  for the  category  of the
          activities  and the  rate of base  salary  of such  employee.  Regular
          Compensation  shall not  include  any  payments  for  overtime,  shift
          differential,  reimbursement for expenses,  finders' fees,  suggestion
          awards,  deferred profit sharing  distributions or similar  nonregular
          payments  (all  as  determined  by  the  Board  of  Directors  or  the
          Committee).

               (d) Account of  Participating  Employee.  All payroll  deductions
          made  for  a   Participating   Employee  shall  be  credited  to  such
          Participating  Employee's  account under the Plan and applied  against
          the purchase price of the Common Shares purchased by the Participating
          Employee  upon  exercise of the Option  granted to such  Participating
          Employee.  A  Participating  Employee may not make any  separate  cash
          payments into such account.

               (e) No Changes in Payroll  Deductions.  A Participating  Employee
          may discontinue  participation in the Plan as provided in Section 7(f)
          below,  but no  other  change  can be made  during  an  Offering  and,
          specifically,  a  Participating  Employee  may not alter the amount of
          such Participating Employee's payroll deductions for that Offering.

               (f)   Termination  and  Withdrawal  of  Payroll   Deductions.   A
          Participating  Employee may terminate and withdraw payroll  deductions
          credited to the account of such Participating  Employee under the Plan
          at any time by giving  written notice to the Board of Directors or the
          Committee,  as the case may be.  All of the  Participating  Employee's
          payroll  deductions  credited to such  Participating  Employee will be
          paid to such  Participating  Employee promptly after receipt of notice
          of withdrawal, and no further payroll deductions will be made from the
          compensation of such Participating Employee during the Offering except
          in accordance with an authorization  for a new payroll deduction filed
          in accordance with Section 7(b) hereof.

                                       10

<PAGE>



               (g) Effect on  Participation.  The withdrawal of a  Participating
          Employee  from  any  Offering  will  not  have  any  effect  upon  the
          eligibility  of such  Participating  Employee  to  participate  in the
          Offering or any  succeeding  Offering or in any similar plan which may
          hereafter be adopted by the Company.

               (h) Termination of Employment. Upon termination of the employment
          of a Participating Employee for any reason,  including retirement (but
          excluding death),  the payroll  deductions  credited to the account of
          such Terminated Employee will be returned to the Terminated  Employee,
          or, in the case of the death of the Terminated Employee, to the person
          or persons  entitled  thereto as  determined  in  accordance  with the
          provisions of Section 17 hereof,  unless the Terminated  Participating
          Employee  continues to be considered a Participating  Employee for the
          purposes  of the Plan  only,  pursuant  to the  provisions  of Section
          6(b)(2)(ii) hereof.

               (i) No Payment of Interest.  No interest shall be paid or allowed
          on any money  credited  to the account of any  Participating  Employee
          pursuant to payroll  deductions  made on behalf of such  Participating
          Employee.

               (j) Use of Funds. All payroll deductions  received or held by the
          Company  under the Plan may be used by the Company  for any  corporate
          purpose,  and the Company  shall not be obligated  to  segregate  such
          payroll deductions.

         8. Issuance and Delivery of Common Shares. As soon as practicable after
the exercise of an Option to purchase Common Shares by a Participating  Employee
as provided herein,  the Board of Directors or the Committee shall undertake and
follow  all  necessary  procedures  to cause the prompt  issuance  of the Common
Shares in the Participating  Employee's name, or, if the Participating  Employee
has so  specified  in his  Participation  Election  Form,  in  the  name  of the
Participating  Employee and another person in joint ownership.  Common Shares so
issued  shall be delivered  promptly to the  Participating  Employee,  provided,
however,  that the  issuance  or  delivery  of  Common  Shares  or both,  may be
postponed, at the sole discretion of the Board of Directors or the Committee, to
enable the  Company to comply with all  applicable  procedures,  regulations  or
listing  requirements of any governmental  agency,  stock exchange or regulatory
authority.

     9.  Participating  Employee's  Rights  as  Stockholder.   No  Participating
Employee shall

                                       11

<PAGE>



have any rights as a stockholder  with respect to any Common  Shares  covered by
the Option granted to such  Participating  Employee until the deemed exercise of
the Option and the date of issuance of one or more stock certificates  issued in
the  Participating  Employee's  name (or in joint names) for such Common Shares.
From the date Common Shares are issued,  such Participating  Employee shall have
the rights which are the same in all  respects as those of all other  holders of
Common Shares, including, without limitation, the right to receive dividends and
to vote the Common Shares  purchased.  No adjustment shall be made for dividends
(ordinary or  extraordinary,  whether in cash,  securities or other property) or
distributions  or other  rights for which the  record  date is prior to the date
such stock certificate is issued, except as provided in Section 11 hereof.

         10.  Participating  Employee's  Agreement to Serve. Each  Participating
Employee receiving an Option shall, as one of the terms of the Option Agreement,
agree that such Participating  Employee will remain in the employ of the Company
or  Subsidiary  for a period of at least one (1) year from the date on which the
Option shall be granted to such Participating  Employee;  and that such employee
will, during such employment,  devote such employee's entire time,  energy,  and
skill to the  service of the Company or a  Subsidiary  as may be required by the
management  thereof,  subject to vacations,  sick leaves, and military absences.
Such  employment,  subject to the provisions of any written contract between the
Company or a Subsidiary and such employee, shall be at the pleasure of the Board
of Directors of the Company or a  Subsidiary,  and at such  compensation  as the
Company or a Subsidiary  shall reasonably  determine.  Neither the action of the
Company  in  establishing  the  Plan nor any  action  taken  by the  Company,  a
Subsidiary  or the Board of  Directors  or the  Committee  under the  provisions
hereof shall be construed as granting the Participating Employee the right to be
retained in the employ of the Company or a  Subsidiary,  or to limit or restrict
the right of the  Company or a  Subsidiary,  as  applicable,  to  terminate  the
employment  of any  employee  of the  Company or a  Subsidiary,  with or without
cause.

         11.      Adjustments on Changes in Capitalization.

                  (a) Changes in Capitalization.  Subject to any required action
         by the stockholders of the Company, the number of Common Shares covered
         by the Plan,  the number of Common Shares  covered by each  outstanding
         Options, and the exercise price per Common Share specified in each such
         Option, shall be proportionately adjusted for any increase or

                                       12

<PAGE>



         decrease in the number of issued Common Shares of the Company resulting
         from a subdivision or  consolidation of Common Shares or the payment of
         a stock  dividend (but only on the Common Shares) or any other increase
         or  decrease  in the  number of such  Common  Shares  effected  without
         receipt of  consideration  by the Company  after the date the Option is
         granted,  so that upon  exercise  of the  Option,  the  optionee  shall
         receive the same  number of Common  Shares  subject to such  optionee's
         outstanding Option immediately before the effective date of such change
         in the number of issued Common Shares.

                  (b) Reorganization, Dissolution or Liquidation. Subject to any
         required  action by the  stockholders  of the  Company,  if the Company
         shall be the surviving corporation in any merger or consolidation, each
         outstanding  Option  shall  pertain to and apply to the  securities  to
         which a  stockholder  of the  number of Common  Shares  subject  to the
         Option would have been  entitled.  A dissolution  or liquidation of the
         Company or a merger or  consolidation  in which the  Company is not the
         surviving corporation, shall cause each outstanding Option to terminate
         as of a date to be fixed by the  Board of  Directors  or the  Committee
         (which date shall be as of or prior to the  effective  date of any such
         dissolution or liquidation or merger or consolidation);  provided, that
         not less than thirty (30) days  written  notice of the date so fixed as
         such  termination  date  shall  be  given  to each  optionee,  and each
         optionee shall, in such event,  have the right,  during the said period
         of thirty (30) days preceding such  termination  date, to exercise such
         optionee's Option in whole or in part in the manner herein set forth.

                  (c)  Change  in Par  Value.  In the  event of a change  in the
         Common Shares of the Company as presently constituted,  which change is
         limited to a change of all of its authorized  share with par value into
         the same  number of shares  with a  different  par value or without par
         value,  the shares  resulting from any change shall be deemed to be the
         Common Shares within the meaning of the Plan.

                  (d) Notice of Adjustments.  To the extent that the adjustments
         set forth in the  foregoing  paragraphs  of this  Section  11 relate to
         capital stock or other securities of the Company, such adjustments,  if
         any,  shall be made by the Board of Directors or the  Committee,  whose
         determination  in that respect shall be final,  binding and conclusive,
         and

                                       13

<PAGE>



         in the case where the Plan is  administered  by the  Committee,  unless
         otherwise  determined  by the Board of  Directors,  provided  that each
         Option granted  pursuant to this Plan shall not be adjusted in a manner
         that  causes the Option to fail to  continue  to qualify as a qualified
         employee  stock  option  within the meaning of Section 423 of the Code.
         The Company  shall give timely notice of any  adjustments  made to each
         holder  of an Option  under  this  Plan and such  adjustments  shall be
         effective and binding on the optionee.

                  (e)  Effect  Upon  Holder of  Option.  Except as  hereinbefore
         expressly  provided in this  Section 11, the holder of an Option  shall
         have no rights by reason of any subdivision or  consolidation of shares
         of stock of any class or the payment of any stock dividend or any other
         increase  or  decrease in the number of shares of stock of any class by
         reason  of  dissolution,   liquidation,   merger,  reorganization,   or
         consolidation,  or spin-off of assets or stock of another  corporation,
         and any  issue by the  Company  of  shares  of stock of any  class,  or
         securities  convertible  into  shares of stock of any class,  shall not
         affect,  and no adjustment by reason thereof shall be made with respect
         to, the number or price of Common Shares subject to the Option. Without
         limiting the generality of the foregoing,  no adjustment  shall be made
         with  respect  to the number or price of Common  Shares  subject to any
         Option  granted  hereunder  upon the occurrence of any of the following
         events:

                          (1) The grant or exercise of any other  options which
                  may  be  granted  or   exercised   under  any   qualified   or
                  nonqualified  stock  option  plan or under any other  employee
                  benefit  plan of the Company  whether or not such options were
                  outstanding  on the date of grant of the Option or  thereafter
                  granted;

                          (2) The sale of any  Common  Shares in the  Company's
                  initial or any subsequent public offering,  including, without
                  limitation,  Common  Shares  sold  upon  the  exercise  of any
                  overallotment  option granted to the underwriter in connection
                  with such offering;

                         (3)  The  sale  of any  Common  Shares  in any  private
                  placement;

                         (4) The issuance, sale or exercise of any warrants to
                  purchase  Common  Shares  whether  or not such  warrants  were
                  outstanding  on the date of grant of the Option or  thereafter
                  issued;

                                       14

<PAGE>



                           (5) The issuance or sale of rights,  promissory notes
                  or  other   securities   convertible  into  Common  Shares  in
                  accordance with the terms of such securities (the "Convertible
                  Securities")  whether or not such Convertible  Securities were
                  outstanding  on the  date  of  grant  of the  Option  or  were
                  thereafter issued or sold;

                           (6)  The  issuance  or  sale of  Common  Shares  upon
                  conversion or exchange of any Convertible Securities,  whether
                  or not  any  adjustment  in the  purchase  price  was  made or
                  required  to be  made  upon  the  issuance  or  sale  of  such
                  Convertible  Securities  and  whether or not such  Convertible
                  Securities were outstanding on the date of grant of the Option
                  or were thereafter issued or sold; or

                           (7) Upon any  amendment  to or change in the terms of
                  any  rights or  warrants  to  subscribe  for or  purchase,  or
                  options for the  purchase  of,  Common  Shares or  Convertible
                  Securities  or in the  terms  of any  Convertible  Securities,
                  including, but not limited to, any extension of any expiration
                  date of any such right,  warrant or option,  any change in any
                  exercise or  purchase  price  provided  for in any such right,
                  warrant or option, any extension of any date through which any
                  Convertible  Securities are  convertible  into or exchangeable
                  for  Common  Shares  or any  change  in the rate at which  any
                  Convertible  Securities are  convertible  into or exchangeable
                  for Common Shares.  

               (f) Right of Company to Make Adjustments.  The grant of an Option
          pursuant to the Plan shall not affect in any way the right or power of
          the Company to make adjustments, reclassification, reorganizations, or
          changes  of its  capital  or  business  structure  or to  merge  or to
          consolidate or to dissolve,  liquidate or sell, or transfer all or any
          part of its business or assets.

     12.  Amendment of the Plan. The Board of Directors may at any time, or from
time to time, amend the Plan in any respect,  except that,  without the approval
of the holders of a majority of the Common Shares of the Company then issued and
outstanding,  represented  at a meeting  and  entitled  to vote  thereat  on the
subject  matter,  no amendment shall be made (a) increasing the number of shares
to be reserved under the Plan (other than as provided in Section 11 hereof), (b)
permitting persons other than Eligible Employees to participate in the Plan, (c)
changing the price at which the

                                       15

<PAGE>



Common  Shares  covered  by an Option may be  purchased  or (d)  increasing  the
maximum  number of Common  Shares  which a  Participating  Employee may purchase
under the Plan.  Furthermore,  the Plan may not,  without  said  approval of the
Stockholders,  be amended in any way which will cause Options issued under it to
fail to meet the  requirements  of employee  stock  purchase plans as defined in
Section 423 of the Code,  and with or without the approval of the  Stockholders,
the Plan may not be amended in any way which will adversely affect the rights of
Participating Employees who were granted Options prior thereto.

     13.  Termination of the Plan. The Plan may be terminated at any time by the
Board of Directors of the Company;  provided,  however,  any Option  outstanding
under the Plan at the time of its  termination  shall remain in effect until the
Option shall have been exercised or shall have expired.

     14.  Effective Date of Plan. The Plan shall become effective on the date of
execution  hereof,  which date is the date the Board of  Directors  approved and
adopted the Plan (the "Effective Date"); provided,  however, if the stockholders
of the Company  shall not have  approved the Plan by the  requisite  vote of the
stockholders  within twelve (12) months after the Effective  Date, then the Plan
shall terminate and all funds standing to each  Participating  Employee's credit
will be refunded to such employee as promptly as possible.

         15. Indemnification of Board of Directors or the Committee. In addition
to such other  rights of  indemnification  as they may have as  Directors  or as
members of the Committee, the members of the Board of Directors or the Committee
shall be indemnified by the Company  against the reasonable  expense,  including
attorneys'  fees  actually  and  necessarily  incurred  in  connection  with the
defenses of any action,  suit or  proceedings,  or in connection with any appeal
therein, to which they or any of them may be party by reason of any action taken
or failure  to act under or in  connection  with the Plan or any Option  granted
thereunder, and against all amounts paid by them in settlement thereof (provided
such  settlement  is  approved  by  independent  legal  counsel  selected by the
Company) or paid by them in satisfaction of a judgment in any such action,  suit
or  proceedings,  except in relation to matters as to which it shall be adjudged
in such action, suit or proceeding that such Board of Directors or the Committee
member is liable for negligence or misconduct in the  performance of his duties;
provided that within sixty (60) days after institution of

                                       16

<PAGE>



any such action,  suit or  proceeding  a Board of Directors or Committee  member
shall in writing  offer the  Company the  opportunity,  as its own  expense,  to
pursue and defend the same.

     16. Notices.  All notices,  elections and authorizations by a Participating
Employee  shall be in writing and delivered in person or by mail to the Board of
Directors or the Committee or an official of the Company designated by the Board
of Directors or the  Committee or by this Plan.  All notices shall be considered
timely if postmarked before midnight of the last day of the relevant period.

     17. Designation of Beneficiary. A Participating Employee may file a written
designation of a beneficiary who is to receive any Common Shares and cash to the
Participating  Employee's  credit under the Plan in the event of such employee's
death prior to delivery to such Participating Employee of such Common Shares and
cash.  Such  designation  of  beneficiary  may be changed  by the  Participating
Employee at any time by written notice to the Secretary of the Company. Upon the
death of a  Participating  Employee  and upon receipt by the Company of proof of
the  identity  and  existence  at  the  Participating   Employee's  death  of  a
beneficiary  validly designated by him under the Plan, the Company shall deliver
such Common Shares and cash to such beneficiary.  In the event of the death of a
Participating  Employee and in the absence of a beneficiary  validly  designated
under the Plan who is living at the time of such Participating Employee's death,
the  Company  shall  deliver  such  Common  Shares and cash to the  executor  or
administrator of the estate of the Participating  Employee, or if no executor or
administrator  has been appointed (to the knowledge of the Company) the Company,
in its  discretion,  may deliver such Common Shares and cash to the spouse or to
any one or more dependents or relatives of the Participating  Employee, or if no
spouse, dependent or relative is known to the Company, then to such other person
as the Company may designate. No designated beneficiary shall prior to the death
of the  Participating  Employee  by whom he has  been  designated,  acquire  any
interest in the Common  Shares or cash  credited to the  Participating  Employee
under the Plan.

     18.  Application  of Funds.  The proceeds  received by the Company from the
sale of Common Shares  pursuant to Options  granted  hereunder  will be used for
general corporate purposes.

     19.  Approval  of  Stockholders.   The  Plan  shall  be  submitted  to  the
Stockholders of the Company within twelve (12) months after the date the Plan is
adopted by the Board of Directors for

                                       17

<PAGE>


the  approval by the holders of at least a majority of the capital  stock of the
Company then outstanding and entitled to vote thereon, present at a meeting.

     20.  Governing  Law.  This  Plan  shall be  governed  by and  construed  in
accordance with the laws of the state of incorporation of the Company.

         Executed as of this 21st day of October, 1997.

                                       COMPU-DAWN, INC.

                                       By:
                                          Mark Honigsfeld
                                          Chief Executive Officer

ATTEST:

By: 
   Louis Libin, Assistant Secretary



K:\WPDOC\CORP\COMPUDAW\AGREEMEN\1997\AMENDQE.SPP

                                                        18

<PAGE>








                                                                 EXHIBIT 23.1


               CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS




COMPU-Dawn, Inc.
Cedarhurst, New York



We hereby consent to the use in this  Registration  Statement on Form S-8 of our
report dated  February  13, 1997,  except as to Note 3 which was dated March 11,
1997,  relating to the  financial  statements  of  COMPU-Dawn,  Inc.  and to the
reference  to  our  firm  under  the  caption  "Experts"  in  this  registration
statement.


                                                 /s/ Lazar Levine & Company LLP
                                                 LAZAR, LEVINE & COMPANY LLP


New York, New York
October 31, 1997



K:\WPDOC\CORP\COMPUDAW\SECFILE\S-8.10


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission